# EDGAR Filing Document

**Accession Number:** 0001540305
**File Stem:** 0001438934-25-001713
**Filing Date:** 2025-8
**Character Count:** 428576
**Document Hash:** 49039b5347dc83cf7669b43a8d531fb4
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001438934-25-001713.hdr.sgml**: 20250826

**ACCESSION NUMBER**: 0001438934-25-001713

**CONFORMED SUBMISSION TYPE**: N-PX

**PUBLIC DOCUMENT COUNT**: 2

**CONFORMED PERIOD OF REPORT**: 20250630

**FILED AS OF DATE**: 20250826

**DATE AS OF CHANGE**: 20250826

**EFFECTIVENESS DATE**: 20250826

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** ETF Series Solutions
- **CENTRAL INDEX KEY:** 0001540305

**ORGANIZATION NAME:**
- **EIN:** 000000000
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1112

**FILING VALUES:**
- **FORM TYPE:** N-PX
- **SEC ACT:** 1940 Act
- **SEC FILE NUMBER:** 811-22668
- **FILM NUMBER:** 251258194

**BUSINESS ADDRESS:**
- **STREET 1:** 615 EAST MICHIGAN ST
- **CITY:** MILWAUKEE
- **STATE:** WI
- **ZIP:** 53202
- **BUSINESS PHONE:** 414-287-3700

**MAIL ADDRESS:**
- **STREET 1:** 615 EAST MICHIGAN ST
- **CITY:** MILWAUKEE
- **STATE:** WI
- **ZIP:** 53202

## FORM N-PX
### ANNUAL REPORT OF PROXY VOTING RECORD

## N-PX: Filer Information

**Filer CIK:** 0001540305

**Date of Report:** 06/30/2025

**Are you a Registered Management Investment Company or an Institutional Manager?:** Registered Management Investment Company

**Is this a LIVE or TEST Filing?:** LIVE

**Is this an electronic copy of an official filing submitted in paper format?:** [ ]

### Submission Contact Information
_Not provided in this filing._

### Notification Information
**Notify via Filing Website only?:** [ ]

## N-PX: Cover Page

**Name of reporting person:** ETF Series Solutions

**Address:** 615 East Michigan Street, Milwaukee, WI 53202

**Telephone number:** 414-516-1645

**Name of agent for service:** Kristina R. Nelson

**Agent Address:** ETF Series Solutions, Milwaukee, WI 53202

**Reporting Period:** Report for the year ended 06/30/2025

**SEC File Number:** 811-22668

**CRD Number (if any):** —

**Other SEC File Number (if any):** —

**LEI (if any):** —

**Report Type (check only one):**

Institutional Manager.

- [ ] Institutional Manager Voting Report

- [ ] Institutional Manager Notice Report

- [ ] Institutional Manager Combination Report

Registered Management Investment Company.

- [x] Fund Voting Report

- [ ] Fund Notice Report

**Do you wish to provide explanatory information pursuant to Special Instruction B.4?:**

- [x] No

- [ ] Yes

**Additional information:** —

## N-PX: Summary - Included Managers

**Number of Included Institutional Managers:** 1

**Included Institutional Managers:** —

## FORM N-PX PROXY VOTING RECORD

| NAME OF ISSUER                   | CUSIP     | MEETING DATE   | VOTE DESCRIPTION                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         | VOTE CATEGORY                                 |   SHARES VOTED |   SHARES ON LOAN | HOW VOTED   |   SHARES VOTED FOR OR AGAINST MANAGEMENT | FOR OR AGAINST MANAGEMENT   | OTHER INFO   |
|:---|:---|:---|:---|:---|---:|---:|:---|---:|:---|:---|
| ACRIVON THERAPEUTICS, INC.       | 004890109 | 06/13/2025     | Election of Class III Director: Peter Blume-Jensen, M.D., Ph.D.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          | DIRECTOR ELECTIONS                            |          23161 |                0 | FOR         |                                    23161 | FOR                         |  |
| ACRIVON THERAPEUTICS, INC.       | 004890109 | 06/13/2025     | Election of Class III Director: Derek DiRocco, Ph.D.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     | DIRECTOR ELECTIONS                            |          23161 |                0 | WITHHOLD    |                                    23161 | AGAINST                     |  |
| ACRIVON THERAPEUTICS, INC.       | 004890109 | 06/13/2025     | Election of Class III Director: Santhosh Palani, Ph.D., C.F.A.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           | DIRECTOR ELECTIONS                            |          23161 |                0 | WITHHOLD    |                                    23161 | AGAINST                     |  |
| ACRIVON THERAPEUTICS, INC.       | 004890109 | 06/13/2025     | To ratify the appointment of PricewaterhouseCoopers LLP as the company's independent registered public accounting firm for the fiscal year ending December 31, 2025.                                                                                                                                                                                                                                                                                                                                                                                                                     | AUDIT-RELATED                                 |          23161 |                0 | FOR         |                                    23161 | FOR                         |  |
| ALLOGENE THERAPEUTICS, INC.      | 019770106 | 06/18/2025     | Election of Director: Elizabeth Barrett                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  | DIRECTOR ELECTIONS                            |          68858 |                0 | WITHHOLD    |                                    68858 | AGAINST                     |  |
| ALLOGENE THERAPEUTICS, INC.      | 019770106 | 06/18/2025     | Election of Director: Arie Belldegrun, M.D.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              | DIRECTOR ELECTIONS                            |          68858 |                0 | WITHHOLD    |                                    68858 | AGAINST                     |  |
| ALLOGENE THERAPEUTICS, INC.      | 019770106 | 06/18/2025     | Election of Director: David Chang, M.D., Ph.D.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           | DIRECTOR ELECTIONS                            |          68858 |                0 | WITHHOLD    |                                    68858 | AGAINST                     |  |
| ALLOGENE THERAPEUTICS, INC.      | 019770106 | 06/18/2025     | To approve, on an advisory basis, the compensation of the Company's named executive officers, as disclosed in the proxy statement.                                                                                                                                                                                                                                                                                                                                                                                                                                                       | SECTION 14A SAY-ON-PAY VOTES                  |          68858 |                0 | FOR         |                                    68858 | FOR                         |  |
| ALLOGENE THERAPEUTICS, INC.      | 019770106 | 06/18/2025     | To ratify the selection by the Audit Committee of the Board of Directors of Ernst  Young LLP as the independent registered public accounting firm of the Company for its fiscal year ending December 31, 2025.                                                                                                                                                                                                                                                                                                                                                                           | AUDIT-RELATED                                 |          68858 |                0 | FOR         |                                    68858 | FOR                         |  |
| APOLLOMICS INC.                  | G0411D107 | 11/14/2024     | Authorize the Board of Directors to effect a Reverse Stock Split.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        | CAPITAL STRUCTURE                             |        1259117 |                0 | FOR         |                                  1259117 | FOR                         |  |
| APOLLOMICS INC.                  | G0411D107 | 11/14/2024     | Authorize an increase in the share capital of the Company.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               | CAPITAL STRUCTURE                             |        1259117 |                0 | AGAINST     |                                  1259117 | AGAINST                     |  |
| APOLLOMICS INC.                  | G0411D107 | 11/14/2024     | Authorize the adjournment of the meeting to a later date or dates to the extent necessary or convenient or in order to solicit additional proxies.                                                                                                                                                                                                                                                                                                                                                                                                                                       | CORPORATE GOVERNANCE                          |        1259117 |                0 | AGAINST     |                                  1259117 | AGAINST                     |  |
| ARCELLX, INC.                    | 03940C100 | 05/28/2025     | Election of Class III Director to hold office until our 2028 annual meeting of stockholders and until their respective successors are elected and qualified: Rami Elghandour                                                                                                                                                                                                                                                                                                                                                                                                             | DIRECTOR ELECTIONS                            |           1751 |                0 | FOR         |                                     1751 | FOR                         |  |
| ARCELLX, INC.                    | 03940C100 | 05/28/2025     | Election of Class III Director to hold office until our 2028 annual meeting of stockholders and until their respective successors are elected and qualified: David Lubner                                                                                                                                                                                                                                                                                                                                                                                                                | DIRECTOR ELECTIONS                            |           1751 |                0 | FOR         |                                     1751 | FOR                         |  |
| ARCELLX, INC.                    | 03940C100 | 05/28/2025     | Election of Class III Director to hold office until our 2028 annual meeting of stockholders and until their respective successors are elected and qualified: Kristin Myers                                                                                                                                                                                                                                                                                                                                                                                                               | DIRECTOR ELECTIONS                            |           1751 |                0 | FOR         |                                     1751 | FOR                         |  |
| ARCELLX, INC.                    | 03940C100 | 05/28/2025     | To approve, on an advisory basis, the compensation of the named executive officers identified in the 2024 Summary Compensation Table in the "Executive Compensation" section of the proxy statement.                                                                                                                                                                                                                                                                                                                                                                                     | SECTION 14A SAY-ON-PAY VOTES                  |           1751 |                0 | FOR         |                                     1751 | FOR                         |  |
| ARCELLX, INC.                    | 03940C100 | 05/28/2025     | To ratify the appointment of PricewaterhouseCoopers LLP as our independent registered public accounting firm for our fiscal year ending December 31, 2025.                                                                                                                                                                                                                                                                                                                                                                                                                               | AUDIT-RELATED                                 |           1751 |                0 | FOR         |                                     1751 | FOR                         |  |
| ARCUS BIOSCIENCES, INC.          | 03969F109 | 06/10/2025     | Election of Director: Yasunori Kaneko, M.D.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              | DIRECTOR ELECTIONS                            |          13922 |                0 | FOR         |                                    13922 | FOR                         |  |
| ARCUS BIOSCIENCES, INC.          | 03969F109 | 06/10/2025     | Election of Director: Patrick Machado, J.D.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              | DIRECTOR ELECTIONS                            |          13922 |                0 | WITHHOLD    |                                    13922 | AGAINST                     |  |
| ARCUS BIOSCIENCES, INC.          | 03969F109 | 06/10/2025     | Election of Director: Andrew Perlman, M.D., Ph.D.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        | DIRECTOR ELECTIONS                            |          13922 |                0 | FOR         |                                    13922 | FOR                         |  |
| ARCUS BIOSCIENCES, INC.          | 03969F109 | 06/10/2025     | Election of Director: Antoni Ribas, M.D., Ph.D.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          | DIRECTOR ELECTIONS                            |          13922 |                0 | WITHHOLD    |                                    13922 | AGAINST                     |  |
| ARCUS BIOSCIENCES, INC.          | 03969F109 | 06/10/2025     | To ratify the selection by the Audit Committee of the Board of Directors of Ernst  Young LLP as the independent registered public accounting firm of Arcus Biosciences for its fiscal year ending December 31, 2025.                                                                                                                                                                                                                                                                                                                                                                     | AUDIT-RELATED                                 |          13922 |                0 | FOR         |                                    13922 | FOR                         |  |
| ARCUS BIOSCIENCES, INC.          | 03969F109 | 06/10/2025     | To approve, on an advisory basis, the compensation of Arcus Biosciences' named executive officers, as disclosed in the Proxy Statement.                                                                                                                                                                                                                                                                                                                                                                                                                                                  | SECTION 14A SAY-ON-PAY VOTES                  |          13922 |                0 | FOR         |                                    13922 | FOR                         |  |
| ARVINAS, INC.                    | 04335A105 | 06/25/2025     | DIRECTOR: Linda Bain                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     | DIRECTOR ELECTIONS                            |          14642 |                0 | ABSTAIN     |                                    14642 | AGAINST                     |  |
| ARVINAS, INC.                    | 04335A105 | 06/25/2025     | DIRECTOR: John Houston, Ph.D.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            | DIRECTOR ELECTIONS                            |          14642 |                0 | ABSTAIN     |                                    14642 | AGAINST                     |  |
| ARVINAS, INC.                    | 04335A105 | 06/25/2025     | DIRECTOR: Laurie Smaldone Alsup                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          | DIRECTOR ELECTIONS                            |          14642 |                0 | ABSTAIN     |                                    14642 | AGAINST                     |  |
| ARVINAS, INC.                    | 04335A105 | 06/25/2025     | To approve, on an advisory basis, the compensation of the Company's named executive officers.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            | SECTION 14A SAY-ON-PAY VOTES                  |          14642 |                0 | FOR         |                                    14642 | FOR                         |  |
| ARVINAS, INC.                    | 04335A105 | 06/25/2025     | Ratification of the appointment of Deloitte  Touche LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2025.                                                                                                                                                                                                                                                                                                                                                                                                                     | AUDIT-RELATED                                 |          14642 |                0 | FOR         |                                    14642 | FOR                         |  |
| AURA BIOSCIENCES, INC.           | 05153U107 | 06/17/2025     | DIRECTOR: E. de los Pinos, Ph.D.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         | DIRECTOR ELECTIONS                            |          16895 |                0 | ABSTAIN     |                                    16895 | AGAINST                     |  |
| AURA BIOSCIENCES, INC.           | 05153U107 | 06/17/2025     | DIRECTOR: Giovanni Mariggi, Ph.D.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        | DIRECTOR ELECTIONS                            |          16895 |                0 | ABSTAIN     |                                    16895 | AGAINST                     |  |
| AURA BIOSCIENCES, INC.           | 05153U107 | 06/17/2025     | To ratify the appointment of Ernst  Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2025.                                                                                                                                                                                                                                                                                                                                                                                                                                         | AUDIT-RELATED                                 |          16895 |                0 | FOR         |                                    16895 | FOR                         |  |
| BICYCLE THERAPEUTICS PLC         | 088786108 | 06/17/2025     | To re-elect as a director Alessandro Riva, who retires in accordance with the Articles of Association.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   | DIRECTOR ELECTIONS                            |          12764 |                0 | AGAINST     |                                    12764 | AGAINST                     |  |
| BICYCLE THERAPEUTICS PLC         | 088786108 | 06/17/2025     | To re-elect as a director Stephen Sands, who retires in accordance with the Articles of Association.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     | DIRECTOR ELECTIONS                            |          12764 |                0 | FOR         |                                    12764 | FOR                         |  |
| BICYCLE THERAPEUTICS PLC         | 088786108 | 06/17/2025     | To approve, on advisory basis, the compensation of our named executive officers, as disclosed in the proxy statement.                                                                                                                                                                                                                                                                                                                                                                                                                                                                    | SECTION 14A SAY-ON-PAY VOTES                  |          12764 |                0 | FOR         |                                    12764 | FOR                         |  |
| BICYCLE THERAPEUTICS PLC         | 088786108 | 06/17/2025     | To ratify the appointment of PricewaterhouseCoopers LLP, a limited liability partnership organized under the laws of England, as our U.S. independent registered public accounting firm for the year ending December 31, 2025.                                                                                                                                                                                                                                                                                                                                                           | AUDIT-RELATED                                 |          12764 |                0 | FOR         |                                    12764 | FOR                         |  |
| BICYCLE THERAPEUTICS PLC         | 088786108 | 06/17/2025     | To re-appoint PricewaterhouseCoopers LLP, a limited liability partnership organized under the laws of England, as our U.K. statutory auditors, to hold office until the conclusion of the next annual general meeting of shareholders.                                                                                                                                                                                                                                                                                                                                                   | AUDIT-RELATED                                 |          12764 |                0 | FOR         |                                    12764 | FOR                         |  |
| BICYCLE THERAPEUTICS PLC         | 088786108 | 06/17/2025     | To authorize the Audit Committee to determine our U.K. statutory auditors' remuneration for the year ending December 31, 2025.                                                                                                                                                                                                                                                                                                                                                                                                                                                           | AUDIT-RELATED                                 |          12764 |                0 | FOR         |                                    12764 | FOR                         |  |
| BICYCLE THERAPEUTICS PLC         | 088786108 | 06/17/2025     | To receive and adopt our U.K. statutory annual accounts and reports for the year ended December 31, 2024 (the "2024 U.K. Annual Report").                                                                                                                                                                                                                                                                                                                                                                                                                                                | OTHER                                         |          12764 |                0 | FOR         |                                    12764 | FOR                         |  |
| BICYCLE THERAPEUTICS PLC         | 088786108 | 06/17/2025     | To approve our directors' remuneration report for the year ended December 31, 2024 (the "directors' remuneration report"), which is set forth as Annex A to the proxy statement.                                                                                                                                                                                                                                                                                                                                                                                                         | COMPENSATION                                  |          12764 |                0 | FOR         |                                    12764 | FOR                         |  |
| BICYCLE THERAPEUTICS PLC         | 088786108 | 06/17/2025     | To approve an amendment to our Amended and Restated 2020 Equity Incentive Plan, which amendment is set forth as Annex C to the proxy statement.                                                                                                                                                                                                                                                                                                                                                                                                                                          | COMPENSATION                                  |          12764 |                0 | AGAINST     |                                    12764 | AGAINST                     |  |
| BIOMEA FUSION, INC.              | 09077A106 | 06/11/2025     | DIRECTOR: Bihua Chen                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     | DIRECTOR ELECTIONS                            |          50550 |                0 | ABSTAIN     |                                    50550 | AGAINST                     |  |
| BIOMEA FUSION, INC.              | 09077A106 | 06/11/2025     | DIRECTOR: Elizabeth Faust, Ph.D.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         | DIRECTOR ELECTIONS                            |          50550 |                0 | ABSTAIN     |                                    50550 | AGAINST                     |  |
| BIOMEA FUSION, INC.              | 09077A106 | 06/11/2025     | DIRECTOR: Sumita Ray, J.D.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               | DIRECTOR ELECTIONS                            |          50550 |                0 | ABSTAIN     |                                    50550 | AGAINST                     |  |
| BIOMEA FUSION, INC.              | 09077A106 | 06/11/2025     | To ratify the appointment of Deloitte  Touche LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2025.                                                                                                                                                                                                                                                                                                                                                                                                                           | AUDIT-RELATED                                 |          50550 |                0 | FOR         |                                    50550 | FOR                         |  |
| BIOMEA FUSION, INC.              | 09077A106 | 06/11/2025     | To approve an amendment to the Company's Amended and Restated Certificate of Incorporation to include an officer exculpation provision that limits the liability of certain of the Company's officers as permitted under current Delaware law.                                                                                                                                                                                                                                                                                                                                           | CORPORATE GOVERNANCE                          |          50550 |                0 | FOR         |                                    50550 | FOR                         |  |
| BIOMEA FUSION, INC.              | 09077A106 | 06/11/2025     | To approve the adjournment of the Annual Meeting to solicit additional proxies to the extent that there are insufficient votes at the Annual Meeting to approve Proposal No. 3.                                                                                                                                                                                                                                                                                                                                                                                                          | CORPORATE GOVERNANCE                          |          50550 |                0 | FOR         |                                    50550 | FOR                         |  |
| BIONTECH SE                      | 09075V102 | 05/16/2025     | Resolution on the appropriation of the balance sheet profit for the 2024 financial year                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  | CAPITAL STRUCTURE                             |           1263 |                0 | FOR         |                                     1263 | FOR                         |  |
| BIONTECH SE                      | 09075V102 | 05/16/2025     | Resolution on the approval of the actions of the Management Board                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        | CORPORATE GOVERNANCE                          |           1263 |                0 | FOR         |                                     1263 | FOR                         |  |
| BIONTECH SE                      | 09075V102 | 05/16/2025     | Resolution on the approval of the actions of the Supervisory Board                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       | CORPORATE GOVERNANCE                          |           1263 |                0 | FOR         |                                     1263 | FOR                         |  |
| BIONTECH SE                      | 09075V102 | 05/16/2025     | Resolution on the appointment of the auditor and the group auditor for the 2025 financial year as well as the auditor for any audit or review of interim financial information; election of the auditor of the sustainability reporting for the 2025 financial year - Resolution on the appointment of the auditor and the group auditor for the 2025 financial year as well as the auditor for any audit or review of interim financial information                                                                                                                                     | AUDIT-RELATED                                 |           1263 |                0 | FOR         |                                     1263 | FOR                         |  |
| BIONTECH SE                      | 09075V102 | 05/16/2025     | Resolution on the appointment of the auditor and the group auditor for the 2025 financial year as well as the auditor for any audit or review of interim financial information; election of the auditor of the sustainability reporting for the 2025 financial year - election of the auditor of the sustainability reporting for the 2025 financial year                                                                                                                                                                                                                                | AUDIT-RELATED                                 |           1263 |                0 | FOR         |                                     1263 | FOR                         |  |
| BIONTECH SE                      | 09075V102 | 05/16/2025     | Resolution on the approval of the Compensation Report                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    | COMPENSATION                                  |           1263 |                0 | AGAINST     |                                     1263 | AGAINST                     |  |
| BIONTECH SE                      | 09075V102 | 05/16/2025     | Resolution on the cancellation of the existing Authorized Capital 2021 and the creation of a new Authorized Capital 2025 with the possibility of excluding subscription rights and corresponding amendment to the Articles of Association                                                                                                                                                                                                                                                                                                                                                | OTHER                                         |           1263 |                0 | FOR         |                                     1263 | FOR                         |  |
| BLUEPRINT MEDICINES CORPORATION  | 09627Y109 | 06/18/2025     | DIRECTOR: Jeffrey Albers                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 | DIRECTOR ELECTIONS                            |           1383 |                0 | ABSTAIN     |                                     1383 | AGAINST                     |  |
| BLUEPRINT MEDICINES CORPORATION  | 09627Y109 | 06/18/2025     | DIRECTOR: Mark Goldberg, M.D.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            | DIRECTOR ELECTIONS                            |           1383 |                0 | ABSTAIN     |                                     1383 | AGAINST                     |  |
| BLUEPRINT MEDICINES CORPORATION  | 09627Y109 | 06/18/2025     | DIRECTOR: John Tsai, M.D.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                | DIRECTOR ELECTIONS                            |           1383 |                0 | ABSTAIN     |                                     1383 | AGAINST                     |  |
| BLUEPRINT MEDICINES CORPORATION  | 09627Y109 | 06/18/2025     | Approval of a non-binding advisory vote on the compensation paid to our named executive officers.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        | SECTION 14A SAY-ON-PAY VOTES                  |           1383 |                0 | FOR         |                                     1383 | FOR                         |  |
| BLUEPRINT MEDICINES CORPORATION  | 09627Y109 | 06/18/2025     | Ratification of the appointment of Ernst  Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2025.                                                                                                                                                                                                                                                                                                                                                                                                                                   | AUDIT-RELATED                                 |           1383 |                0 | FOR         |                                     1383 | FOR                         |  |
| BRISTOL-MYERS SQUIBB COMPANY     | 110122108 | 05/06/2025     | Election of Director: Peter J. Arduini                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   | DIRECTOR ELECTIONS                            |           3149 |                0 | FOR         |                                     3149 | FOR                         |  |
| BRISTOL-MYERS SQUIBB COMPANY     | 110122108 | 05/06/2025     | Election of Director: Deepak L. Bhatt, M.D., M.P.H., M.B.A.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              | DIRECTOR ELECTIONS                            |           3149 |                0 | FOR         |                                     3149 | FOR                         |  |
| BRISTOL-MYERS SQUIBB COMPANY     | 110122108 | 05/06/2025     | Election of Director: Christopher S. Boerner, Ph.D.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      | DIRECTOR ELECTIONS                            |           3149 |                0 | FOR         |                                     3149 | FOR                         |  |
| BRISTOL-MYERS SQUIBB COMPANY     | 110122108 | 05/06/2025     | Election of Director: Julia A. Haller, M.D.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              | DIRECTOR ELECTIONS                            |           3149 |                0 | FOR         |                                     3149 | FOR                         |  |
| BRISTOL-MYERS SQUIBB COMPANY     | 110122108 | 05/06/2025     | Election of Director: Manuel Hidalgo Medina, M.D., Ph.D.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 | DIRECTOR ELECTIONS                            |           3149 |                0 | FOR         |                                     3149 | FOR                         |  |
| BRISTOL-MYERS SQUIBB COMPANY     | 110122108 | 05/06/2025     | Election of Director: Michael R. McMullen                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                | DIRECTOR ELECTIONS                            |           3149 |                0 | FOR         |                                     3149 | FOR                         |  |
| BRISTOL-MYERS SQUIBB COMPANY     | 110122108 | 05/06/2025     | Election of Director: Paula A. Price                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     | DIRECTOR ELECTIONS                            |           3149 |                0 | FOR         |                                     3149 | FOR                         |  |
| BRISTOL-MYERS SQUIBB COMPANY     | 110122108 | 05/06/2025     | Election of Director: Derica W. Rice                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     | DIRECTOR ELECTIONS                            |           3149 |                0 | FOR         |                                     3149 | FOR                         |  |
| BRISTOL-MYERS SQUIBB COMPANY     | 110122108 | 05/06/2025     | Election of Director: Theodore R. Samuels                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                | DIRECTOR ELECTIONS                            |           3149 |                0 | FOR         |                                     3149 | FOR                         |  |
| BRISTOL-MYERS SQUIBB COMPANY     | 110122108 | 05/06/2025     | Election of Director: Karen H. Vousden, Ph.D.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            | DIRECTOR ELECTIONS                            |           3149 |                0 | FOR         |                                     3149 | FOR                         |  |
| BRISTOL-MYERS SQUIBB COMPANY     | 110122108 | 05/06/2025     | Election of Director: Phyllis R. Yale                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    | DIRECTOR ELECTIONS                            |           3149 |                0 | FOR         |                                     3149 | FOR                         |  |
| BRISTOL-MYERS SQUIBB COMPANY     | 110122108 | 05/06/2025     | Advisory Vote to Approve the Compensation of our Named Executive Officers                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                | SECTION 14A SAY-ON-PAY VOTES                  |           3149 |                0 | FOR         |                                     3149 | FOR                         |  |
| BRISTOL-MYERS SQUIBB COMPANY     | 110122108 | 05/06/2025     | Ratification of the Appointment of an Independent Registered Public Accounting Firm                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      | AUDIT-RELATED                                 |           3149 |                0 | FOR         |                                     3149 | FOR                         |  |
| BRISTOL-MYERS SQUIBB COMPANY     | 110122108 | 05/06/2025     | Shareholder Proposal on Corporate Financial Sustainability                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               | OTHER SOCIAL ISSUES                           |           3149 |                0 | AGAINST     |                                     3149 | FOR                         |  |
| BRISTOL-MYERS SQUIBB COMPANY     | 110122108 | 05/06/2025     | Shareholder Proposal on a Request to Cease DEI Efforts                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   | OTHER SOCIAL ISSUES                           |           3149 |                0 | AGAINST     |                                     3149 | FOR                         |  |
| CARIBOU BIOSCIENCES, INC.        | 142038108 | 06/12/2025     | Election of Class I Director to serve until the Company's 2028 annual meeting of stockholders: Scott Braunstein, M.D.                                                                                                                                                                                                                                                                                                                                                                                                                                                                    | DIRECTOR ELECTIONS                            |         124889 |                0 | FOR         |                                   124889 | FOR                         |  |
| CARIBOU BIOSCIENCES, INC.        | 142038108 | 06/12/2025     | Election of Class I Director to serve until the Company's 2028 annual meeting of stockholders: Ran Zheng, M.S.                                                                                                                                                                                                                                                                                                                                                                                                                                                                           | DIRECTOR ELECTIONS                            |         124889 |                0 | WITHHOLD    |                                   124889 | AGAINST                     |  |
| CARIBOU BIOSCIENCES, INC.        | 142038108 | 06/12/2025     | To ratify the appointment of Deloitte  Touche LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2025.                                                                                                                                                                                                                                                                                                                                                                                                                           | AUDIT-RELATED                                 |         124889 |                0 | FOR         |                                   124889 | FOR                         |  |
| CARIBOU BIOSCIENCES, INC.        | 142038108 | 06/12/2025     | To approve an amendment to the Company's amended and restated certificate of incorporation to effect a reverse stock split of the Company's common stock at a ratio ranging from any whole number between 1-for-5 and 1-for-50, inclusive, as determined by the Board of Directors in its discretion, subject to the Board of Directors' authority to abandon such amendment in its discretion.                                                                                                                                                                                          | CAPITAL STRUCTURE                             |         124889 |                0 | FOR         |                                   124889 | FOR                         |  |
| CARIBOU BIOSCIENCES, INC.        | 142038108 | 06/12/2025     | To approve the adjournment of the 2025 Annual Meeting to a later date or dates, if necessary, to permit further solicitation and voting of proxies in the event there are not sufficient votes in favor of any of proposals 1-3 above or if there are not sufficient shares present to establish a quorum.                                                                                                                                                                                                                                                                               | CORPORATE GOVERNANCE                          |         124889 |                0 | AGAINST     |                                   124889 | AGAINST                     |  |
| COMPASS THERAPEUTICS, INC.       | 20454B104 | 06/11/2025     | DIRECTOR: Philip J Ferneau MBA JD                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        | DIRECTOR ELECTIONS                            |          54207 |                0 | ABSTAIN     |                                    54207 | AGAINST                     |  |
| COMPASS THERAPEUTICS, INC.       | 20454B104 | 06/11/2025     | DIRECTOR: James P. Boylan, M.B.A.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        | DIRECTOR ELECTIONS                            |          54207 |                0 | FOR         |                                    54207 | FOR                         |  |
| COMPASS THERAPEUTICS, INC.       | 20454B104 | 06/11/2025     | DIRECTOR: Carl L. Gordon PhD. CFA                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        | DIRECTOR ELECTIONS                            |          54207 |                0 | FOR         |                                    54207 | FOR                         |  |
| COMPASS THERAPEUTICS, INC.       | 20454B104 | 06/11/2025     | Ratification of the appointment of CohnReznick LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2025.                                                                                                                                                                                                                                                                                                                                                                                                                          | AUDIT-RELATED                                 |          54207 |                0 | FOR         |                                    54207 | FOR                         |  |
| CULLINAN THERAPEUTICS, INC.      | 230031106 | 06/12/2025     | DIRECTOR: Anthony Rosenberg                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              | DIRECTOR ELECTIONS                            |          14107 |                0 | FOR         |                                    14107 | FOR                         |  |
| CULLINAN THERAPEUTICS, INC.      | 230031106 | 06/12/2025     | DIRECTOR: David P. Ryan, M.D.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            | DIRECTOR ELECTIONS                            |          14107 |                0 | FOR         |                                    14107 | FOR                         |  |
| CULLINAN THERAPEUTICS, INC.      | 230031106 | 06/12/2025     | DIRECTOR: Mary Thistle                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   | DIRECTOR ELECTIONS                            |          14107 |                0 | FOR         |                                    14107 | FOR                         |  |
| CULLINAN THERAPEUTICS, INC.      | 230031106 | 06/12/2025     | Proposal to ratify the appointment of KPMG LLP as Cullinan Therapeutics' independent registered public accounting firm for the fiscal year ending December 31, 2025.                                                                                                                                                                                                                                                                                                                                                                                                                     | AUDIT-RELATED                                 |          14107 |                0 | FOR         |                                    14107 | FOR                         |  |
| CULLINAN THERAPEUTICS, INC.      | 230031106 | 06/12/2025     | Proposal to vote, on an advisory basis, to approve our named executive officer compensation.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             | SECTION 14A SAY-ON-PAY VOTES                  |          14107 |                0 | FOR         |                                    14107 | FOR                         |  |
| CULLINAN THERAPEUTICS, INC.      | 230031106 | 06/12/2025     | Proposal to vote, on an advisory basis, on the frequency of future advisory votes on our named executive officer compensation.                                                                                                                                                                                                                                                                                                                                                                                                                                                           | SECTION 14A SAY-ON-PAY VOTES                  |          14107 |                0 | 1 YEAR      |                                    14107 | FOR                         |  |
| DAY ONE BIOPHARMACEUTICALS, INC. | 23954D109 | 06/02/2025     | DIRECTOR: Natalie Holles                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 | DIRECTOR ELECTIONS                            |          14693 |                0 | FOR         |                                    14693 | FOR                         |  |
| DAY ONE BIOPHARMACEUTICALS, INC. | 23954D109 | 06/02/2025     | DIRECTOR: Garry Nicholson                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                | DIRECTOR ELECTIONS                            |          14693 |                0 | ABSTAIN     |                                    14693 | AGAINST                     |  |
| DAY ONE BIOPHARMACEUTICALS, INC. | 23954D109 | 06/02/2025     | Ratification of the appointment of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for the year ending December 31, 2025.                                                                                                                                                                                                                                                                                                                                                                                                                      | AUDIT-RELATED                                 |          14693 |                0 | FOR         |                                    14693 | FOR                         |  |
| DAY ONE BIOPHARMACEUTICALS, INC. | 23954D109 | 06/02/2025     | Approval, on a non-binding advisory basis, of the compensation of our named executive officers.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          | SECTION 14A SAY-ON-PAY VOTES                  |          14693 |                0 | FOR         |                                    14693 | FOR                         |  |
| ENLIVEN THERAPEUTICS, INC.       | 29337E102 | 06/24/2025     | Election of Class II Director to serve until the 2028 annual meeting of stockholders or until their successors are duly elected and qualified or until their earlier death, resignation or removal: Rahul D. Ballal, Ph.D.                                                                                                                                                                                                                                                                                                                                                               | DIRECTOR ELECTIONS                            |           6055 |                0 | FOR         |                                     6055 | FOR                         |  |
| ENLIVEN THERAPEUTICS, INC.       | 29337E102 | 06/24/2025     | Election of Class II Director to serve until the 2028 annual meeting of stockholders or until their successors are duly elected and qualified or until their earlier death, resignation or removal: Jake Bauer, M.B.A                                                                                                                                                                                                                                                                                                                                                                    | DIRECTOR ELECTIONS                            |           6055 |                0 | FOR         |                                     6055 | FOR                         |  |
| ENLIVEN THERAPEUTICS, INC.       | 29337E102 | 06/24/2025     | Election of Class II Director to serve until the 2028 annual meeting of stockholders or until their successors are duly elected and qualified or until their earlier death, resignation or removal: Andrew Phillips, Ph.D.                                                                                                                                                                                                                                                                                                                                                               | DIRECTOR ELECTIONS                            |           6055 |                0 | WITHHOLD    |                                     6055 | AGAINST                     |  |
| ENLIVEN THERAPEUTICS, INC.       | 29337E102 | 06/24/2025     | To ratify the appointment of Deloitte  Touche LLP as our independent registered public accounting firm for fiscal year ending December 31, 2025.                                                                                                                                                                                                                                                                                                                                                                                                                                         | AUDIT-RELATED                                 |           6055 |                0 | FOR         |                                     6055 | FOR                         |  |
| ERASCA, INC.                     | 29479A108 | 06/24/2025     | Election of Class I Director for a three-year term expiring at the 2028 Annual Meeting of Stockholders: Jonathan E. Lim, M.D.                                                                                                                                                                                                                                                                                                                                                                                                                                                            | DIRECTOR ELECTIONS                            |          87251 |                0 | FOR         |                                    87251 | FOR                         |  |
| ERASCA, INC.                     | 29479A108 | 06/24/2025     | Election of Class I Director for a three-year term expiring at the 2028 Annual Meeting of Stockholders: James A. Bristol, Ph.D.                                                                                                                                                                                                                                                                                                                                                                                                                                                          | DIRECTOR ELECTIONS                            |          87251 |                0 | WITHHOLD    |                                    87251 | AGAINST                     |  |
| ERASCA, INC.                     | 29479A108 | 06/24/2025     | Election of Class I Director for a three-year term expiring at the 2028 Annual Meeting of Stockholders: Valerie Harding - Start, Ph.D.                                                                                                                                                                                                                                                                                                                                                                                                                                                   | DIRECTOR ELECTIONS                            |          87251 |                0 | WITHHOLD    |                                    87251 | AGAINST                     |  |
| ERASCA, INC.                     | 29479A108 | 06/24/2025     | To ratify the appointment of KPMG LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2025                                                                                                                                                                                                                                                                                                                                                                                                                                                  | AUDIT-RELATED                                 |          87251 |                0 | FOR         |                                    87251 | FOR                         |  |
| EXELIXIS, INC.                   | 30161Q104 | 05/28/2025     | Election of Director to hold office until the next Annual Meeting of Stockholders: Mary C. Beckerle, Ph.D.                                                                                                                                                                                                                                                                                                                                                                                                                                                                               | DIRECTOR ELECTIONS                            |           5730 |                0 | FOR         |                                     5730 | FOR                         |  |
| EXELIXIS, INC.                   | 30161Q104 | 05/28/2025     | Election of Director to hold office until the next Annual Meeting of Stockholders: S. Gail Eckhardt, M.D.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                | DIRECTOR ELECTIONS                            |           5730 |                0 | FOR         |                                     5730 | FOR                         |  |
| EXELIXIS, INC.                   | 30161Q104 | 05/28/2025     | Election of Director to hold office until the next Annual Meeting of Stockholders: Maria C. Freire, Ph.D.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                | DIRECTOR ELECTIONS                            |           5730 |                0 | FOR         |                                     5730 | FOR                         |  |
| EXELIXIS, INC.                   | 30161Q104 | 05/28/2025     | Election of Director to hold office until the next Annual Meeting of Stockholders: Tomas J. Heyman                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       | DIRECTOR ELECTIONS                            |           5730 |                0 | FOR         |                                     5730 | FOR                         |  |
| EXELIXIS, INC.                   | 30161Q104 | 05/28/2025     | Election of Director to hold office until the next Annual Meeting of Stockholders: David E. Johnson                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      | DIRECTOR ELECTIONS                            |           5730 |                0 | FOR         |                                     5730 | FOR                         |  |
| EXELIXIS, INC.                   | 30161Q104 | 05/28/2025     | Election of Director to hold office until the next Annual Meeting of Stockholders: Michael M. Morrissey, Ph.D.                                                                                                                                                                                                                                                                                                                                                                                                                                                                           | DIRECTOR ELECTIONS                            |           5730 |                0 | FOR         |                                     5730 | FOR                         |  |
| EXELIXIS, INC.                   | 30161Q104 | 05/28/2025     | Election of Director to hold office until the next Annual Meeting of Stockholders: Robert L. Oliver, Jr.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 | DIRECTOR ELECTIONS                            |           5730 |                0 | FOR         |                                     5730 | FOR                         |  |
| EXELIXIS, INC.                   | 30161Q104 | 05/28/2025     | Election of Director to hold office until the next Annual Meeting of Stockholders: Stelios Papadopoulos, Ph.D.                                                                                                                                                                                                                                                                                                                                                                                                                                                                           | DIRECTOR ELECTIONS                            |           5730 |                0 | FOR         |                                     5730 | FOR                         |  |
| EXELIXIS, INC.                   | 30161Q104 | 05/28/2025     | Election of Director to hold office until the next Annual Meeting of Stockholders: George Poste, DVM, Ph.D., FRS                                                                                                                                                                                                                                                                                                                                                                                                                                                                         | DIRECTOR ELECTIONS                            |           5730 |                0 | FOR         |                                     5730 | FOR                         |  |
| EXELIXIS, INC.                   | 30161Q104 | 05/28/2025     | Election of Director to hold office until the next Annual Meeting of Stockholders: Julie Anne Smith                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      | DIRECTOR ELECTIONS                            |           5730 |                0 | FOR         |                                     5730 | FOR                         |  |
| EXELIXIS, INC.                   | 30161Q104 | 05/28/2025     | Election of Director to hold office until the next Annual Meeting of Stockholders: Jack L. Wyszomierski                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  | DIRECTOR ELECTIONS                            |           5730 |                0 | FOR         |                                     5730 | FOR                         |  |
| EXELIXIS, INC.                   | 30161Q104 | 05/28/2025     | To ratify the selection by the Audit Committee of the Board of Directors of Ernst  Young LLP as Exelixis' independent registered public accounting firm for the fiscal year ending January 2, 2026.                                                                                                                                                                                                                                                                                                                                                                                      | AUDIT-RELATED                                 |           5730 |                0 | FOR         |                                     5730 | FOR                         |  |
| EXELIXIS, INC.                   | 30161Q104 | 05/28/2025     | To approve, on an advisory basis, the compensation of Exelixis' named executive officers, as disclosed in the accompanying Proxy Statement.                                                                                                                                                                                                                                                                                                                                                                                                                                              | SECTION 14A SAY-ON-PAY VOTES                  |           5730 |                0 | FOR         |                                     5730 | FOR                         |  |
| EXSCIENTIA PLC                   | 30223G102 | 11/12/2024     | Voting "FOR" or "AGAINST" the proposed scheme of arrangement (the "Scheme").                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             | EXTRAORDINARY TRANSACTIONS                    |          31095 |                0 | FOR         |                                    31095 | FOR                         |  |
| EXSCIENTIA PLC                   | 30223G102 | 11/12/2024     | To implement the Scheme of Arrangement, as set out in the notice of the Exscientia General Meeting, including: (a) authorising the directors of the Company (or a duly authorized committee of the directors) to take all such action as they may consider necessary or appropriate for carrying the Scheme of Arrangement into effect; (b) the amendment to the articles of association of the Company as set out in the Notice of the Exscientia General Meeting; (c) directing the Company to deliver the Court Order... (due to space limits, see proxy material for full proposal). | CORPORATE GOVERNANCE                          |          31095 |                0 | FOR         |                                    31095 | FOR                         |  |
| FATE THERAPEUTICS, INC.          | 31189P102 | 05/29/2025     | Election of Class III Director: Dr. Shefali Agarwal                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      | DIRECTOR ELECTIONS                            |         131830 |                0 | FOR         |                                   131830 | FOR                         |  |
| FATE THERAPEUTICS, INC.          | 31189P102 | 05/29/2025     | Election of Class III Director: Dr. Bahram Valamehr                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      | DIRECTOR ELECTIONS                            |         131830 |                0 | FOR         |                                   131830 | FOR                         |  |
| FATE THERAPEUTICS, INC.          | 31189P102 | 05/29/2025     | Election of Class III Director: Matthew C. Abernethy                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     | DIRECTOR ELECTIONS                            |         131830 |                0 | FOR         |                                   131830 | FOR                         |  |
| FATE THERAPEUTICS, INC.          | 31189P102 | 05/29/2025     | To approve the ratification of Ernst  Young LLP as the independent registered public accounting firm of the Company for its fiscal year ending December 31, 2025.                                                                                                                                                                                                                                                                                                                                                                                                                        | AUDIT-RELATED                                 |         131830 |                0 | FOR         |                                   131830 | FOR                         |  |
| FATE THERAPEUTICS, INC.          | 31189P102 | 05/29/2025     | To approve, on a non-binding advisory basis, the compensation of the Company's named executive officers as disclosed in the proxy statement.                                                                                                                                                                                                                                                                                                                                                                                                                                             | SECTION 14A SAY-ON-PAY VOTES                  |         131830 |                0 | FOR         |                                   131830 | FOR                         |  |
| FATE THERAPEUTICS, INC.          | 31189P102 | 05/29/2025     | To recommend, on a non-binding advisory basis, the frequency of future non-binding stockholder advisory votes to approve the compensation of the Company's named executive officers.                                                                                                                                                                                                                                                                                                                                                                                                     | SECTION 14A SAY-ON-PAY VOTES                  |         131830 |                0 | 1 YEAR      |                                   131830 | FOR                         |  |
| FATE THERAPEUTICS, INC.          | 31189P102 | 05/29/2025     | To approve the amendment of our Amended and Restated Certificate of Incorporation to increase the authorized number of shares of common stock from 250,000,000 to 350,000,000.                                                                                                                                                                                                                                                                                                                                                                                                           | CAPITAL STRUCTURE                             |         131830 |                0 | FOR         |                                   131830 | FOR                         |  |
| FATE THERAPEUTICS, INC.          | 31189P102 | 05/29/2025     | To approve the amendment and restatement of the Company's 2022 Stock Option and Incentive Plan to increase the number of shares of common stock reserved for issuance thereunder.                                                                                                                                                                                                                                                                                                                                                                                                        | COMPENSATION                                  |         131830 |                0 | AGAINST     |                                   131830 | AGAINST                     |  |
| FATE THERAPEUTICS, INC.          | 31189P102 | 05/29/2025     | To approve the adjournment of the Annual Meeting to the extent there are insufficient votes at the Annual Meeting to approve any of the above proposals.                                                                                                                                                                                                                                                                                                                                                                                                                                 | CORPORATE GOVERNANCE                          |         131830 |                0 | AGAINST     |                                   131830 | AGAINST                     |  |
| FOGHORN THERAPEUTICS INC.        | 344174107 | 06/17/2025     | Election of Class II Director for a three-year term: Stuart Duty                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         | DIRECTOR ELECTIONS                            |          27693 |                0 | FOR         |                                    27693 | FOR                         |  |
| FOGHORN THERAPEUTICS INC.        | 344174107 | 06/17/2025     | Election of Class II Director for a three-year term: Neil J. Gallagher, M.D., PH.D.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      | DIRECTOR ELECTIONS                            |          27693 |                0 | FOR         |                                    27693 | FOR                         |  |
| FOGHORN THERAPEUTICS INC.        | 344174107 | 06/17/2025     | Election of Class II Director for a three-year term: Adrian Gottschalk                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   | DIRECTOR ELECTIONS                            |          27693 |                0 | AGAINST     |                                    27693 | AGAINST                     |  |
| FOGHORN THERAPEUTICS INC.        | 344174107 | 06/17/2025     | Election of Class II Director for a three-year term: Ian F. Smith                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        | DIRECTOR ELECTIONS                            |          27693 |                0 | AGAINST     |                                    27693 | AGAINST                     |  |
| FOGHORN THERAPEUTICS INC.        | 344174107 | 06/17/2025     | To ratify the selection of Deloitte  Touche LLP as the independent registered public accounting firm for the Company for the fiscal year ending December 31, 2025.                                                                                                                                                                                                                                                                                                                                                                                                                       | AUDIT-RELATED                                 |          27693 |                0 | FOR         |                                    27693 | FOR                         |  |
| GENELUX CORPORATION              | 36870H103 | 08/01/2024     | DIRECTOR: Mary Mirabelli                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 | DIRECTOR ELECTIONS                            |          36938 |                0 | ABSTAIN     |                                    36938 | AGAINST                     |  |
| GENELUX CORPORATION              | 36870H103 | 08/01/2024     | DIRECTOR: John Thomas                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    | DIRECTOR ELECTIONS                            |          36938 |                0 | ABSTAIN     |                                    36938 | AGAINST                     |  |
| GENELUX CORPORATION              | 36870H103 | 08/01/2024     | To ratify the appointment of Weinberg  Company, P.A. as the Company's registered independent public accounting firm for the year ending December 31, 2024.                                                                                                                                                                                                                                                                                                                                                                                                                               | AUDIT-RELATED                                 |          36938 |                0 | FOR         |                                    36938 | FOR                         |  |
| GENMAB A S                       | 372303206 | 03/12/2025     | Presentation and adoption of the audited Annual Report and discharge of Board of Directors and Executive Management.                                                                                                                                                                                                                                                                                                                                                                                                                                                                     | OTHER                                         |           5921 |                0 | FOR         |                                     5921 | FOR                         |  |
| GENMAB A S                       | 372303206 | 03/12/2025     | Resolution on the distribution of profits as recorded in the adopted Annual Report.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      | CAPITAL STRUCTURE                             |           5921 |                0 | FOR         |                                     5921 | FOR                         |  |
| GENMAB A S                       | 372303206 | 03/12/2025     | Advisory vote on the Compensation Report.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                | SECTION 14A SAY-ON-PAY VOTES                  |           5921 |                0 | FOR         |                                     5921 | FOR                         |  |
| GENMAB A S                       | 372303206 | 03/12/2025     | Re-election of Director: Deirdre P. Connelly                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             | DIRECTOR ELECTIONS                            |           5921 |                0 | FOR         |                                     5921 | FOR                         |  |
| GENMAB A S                       | 372303206 | 03/12/2025     | Re-election of Director: Pernille Erenbjerg                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              | DIRECTOR ELECTIONS                            |           5921 |                0 | FOR         |                                     5921 | FOR                         |  |
| GENMAB A S                       | 372303206 | 03/12/2025     | Re-election of Director: Rolf Hoffmann                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   | DIRECTOR ELECTIONS                            |           5921 |                0 | FOR         |                                     5921 | FOR                         |  |
| GENMAB A S                       | 372303206 | 03/12/2025     | Re-election of Director: Elizabeth O'Farrell                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             | DIRECTOR ELECTIONS                            |           5921 |                0 | FOR         |                                     5921 | FOR                         |  |
| GENMAB A S                       | 372303206 | 03/12/2025     | Re-election of Director: Dr. Paolo Paoletti                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              | DIRECTOR ELECTIONS                            |           5921 |                0 | FOR         |                                     5921 | FOR                         |  |
| GENMAB A S                       | 372303206 | 03/12/2025     | Re-election of Director: Dr. Anders Gersel Pedersen                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      | DIRECTOR ELECTIONS                            |           5921 |                0 | FOR         |                                     5921 | FOR                         |  |
| GENMAB A S                       | 372303206 | 03/12/2025     | Election of auditor: Re-election of Deloitte Statsautoriseret Revisionspartnerselskab                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    | AUDIT-RELATED                                 |           5921 |                0 | FOR         |                                     5921 | FOR                         |  |
| GENMAB A S                       | 372303206 | 03/12/2025     | Adoption of amendments to Remuneration Policy for the Board of Directors and Executive Management of Genmab A/S.                                                                                                                                                                                                                                                                                                                                                                                                                                                                         | COMPENSATION; CORPORATE GOVERNANCE            |           5921 |                0 | AGAINST     |                                     5921 | AGAINST                     |  |
| GENMAB A S                       | 372303206 | 03/12/2025     | Approval of remuneration to the Board of Directors for 2025.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             | COMPENSATION                                  |           5921 |                0 | AGAINST     |                                     5921 | AGAINST                     |  |
| GENMAB A S                       | 372303206 | 03/12/2025     | Proposal to reduce the Company's share capital for the purpose of cancelling treasury shares.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            | CAPITAL STRUCTURE                             |           5921 |                0 | FOR         |                                     5921 | FOR                         |  |
| GENMAB A S                       | 372303206 | 03/12/2025     | Authorization to the Board of Directors to mandate the Company to acquire treasury shares.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               | CAPITAL STRUCTURE                             |           5921 |                0 | FOR         |                                     5921 | FOR                         |  |
| GENMAB A S                       | 372303206 | 03/12/2025     | Authorization to the Board of Directors to let the Company issue warrants.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               | CAPITAL STRUCTURE; COMPENSATION               |           5921 |                0 | FOR         |                                     5921 | FOR                         |  |
| GENMAB A S                       | 372303206 | 03/12/2025     | Authorization of the Chair of the General Meeting to register resolutions passed by the General Meeting.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 | OTHER                                         |           5921 |                0 | FOR         |                                     5921 | FOR                         |  |
| GERON CORPORATION                | 374163103 | 05/21/2025     | DIRECTOR: Dawn C. Bir                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    | DIRECTOR ELECTIONS                            |          36015 |                0 | FOR         |                                    36015 | FOR                         |  |
| GERON CORPORATION                | 374163103 | 05/21/2025     | DIRECTOR: Elizabeth G. O'Farrell                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         | DIRECTOR ELECTIONS                            |          36015 |                0 | FOR         |                                    36015 | FOR                         |  |
| GERON CORPORATION                | 374163103 | 05/21/2025     | To approve an amendment to our 2018 Equity Incentive Plan to, among other items, increase the total number of shares of our common stock issuable thereunder by 20,000,000 shares.                                                                                                                                                                                                                                                                                                                                                                                                       | COMPENSATION                                  |          36015 |                0 | FOR         |                                    36015 | FOR                         |  |
| GERON CORPORATION                | 374163103 | 05/21/2025     | To approve an amendment to our 2014 Employee Stock Purchase Plan to increase the number of shares of our common stock issuable thereunder by 6,000,000 shares.                                                                                                                                                                                                                                                                                                                                                                                                                           | CAPITAL STRUCTURE                             |          36015 |                0 | FOR         |                                    36015 | FOR                         |  |
| GERON CORPORATION                | 374163103 | 05/21/2025     | To approve, on an advisory basis, the compensation of our Named Executive Officers, as disclosed in our Proxy Statement.                                                                                                                                                                                                                                                                                                                                                                                                                                                                 | SECTION 14A SAY-ON-PAY VOTES                  |          36015 |                0 | FOR         |                                    36015 | FOR                         |  |
| GERON CORPORATION                | 374163103 | 05/21/2025     | To ratify the selection of Ernst  Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2025.                                                                                                                                                                                                                                                                                                                                                                                                                                           | AUDIT-RELATED                                 |          36015 |                0 | FOR         |                                    36015 | FOR                         |  |
| GINKGO BIOWORKS HOLDINGS, INC.   | 37611X100 | 08/14/2024     | To approve Article V, Section 1(c) of the Company's Amended and Restated Charter to effect, at the discretion of the Board, a reverse stock split of the issued  outstanding shares of Class A and Class B common stock, which would combine a whole number of outstanding shares of the Class A and Class B common stock in a range of not less than one-for-twenty shares and not more than one-for-forty shares into one share of Class A common stock or Class B common stock, as applicable, and reduce the number of outstanding shares of Class A and Class B common stock.       | CAPITAL STRUCTURE                             |         214961 |                0 | FOR         |                                   214961 | FOR                         |  |
| GINKGO BIOWORKS HOLDINGS, INC.   | 37611X100 | 08/14/2024     | To approve Article VIII of the Company's Amended and Restated Certificate of Incorporation to permit officer exculpation.                                                                                                                                                                                                                                                                                                                                                                                                                                                                | CORPORATE GOVERNANCE                          |         214961 |                0 | AGAINST     |                                   214961 | AGAINST                     |  |
| GINKGO BIOWORKS HOLDINGS, INC.   | 37611X100 | 08/14/2024     | To approve the Company's Amended and Restated Certificate of Incorporation, which has been updated to, among other things, remove provisions related to our merger with Soaring Eagle Acquisition Corp. and our domestication process, which are no longer relevant to our business.                                                                                                                                                                                                                                                                                                     | CORPORATE GOVERNANCE                          |         214961 |                0 | FOR         |                                   214961 | FOR                         |  |
| GINKGO BIOWORKS HOLDINGS, INC.   | 37611X209 | 06/12/2025     | Election of Class A Director: Ross Fubini                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                | DIRECTOR ELECTIONS                            |          16395 |                0 | FOR         |                                    16395 | FOR                         |  |
| GINKGO BIOWORKS HOLDINGS, INC.   | 37611X209 | 06/12/2025     | Election of Class A Director: Christian Henry                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            | DIRECTOR ELECTIONS                            |          16395 |                0 | FOR         |                                    16395 | FOR                         |  |
| GINKGO BIOWORKS HOLDINGS, INC.   | 37611X209 | 06/12/2025     | Election of Class A Director: Sri Kosuri                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 | DIRECTOR ELECTIONS                            |          16395 |                0 | FOR         |                                    16395 | FOR                         |  |
| GINKGO BIOWORKS HOLDINGS, INC.   | 37611X209 | 06/12/2025     | Election of Class A Director: Shyam Sankar                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               | DIRECTOR ELECTIONS                            |          16395 |                0 | AGAINST     |                                    16395 | AGAINST                     |  |
| GINKGO BIOWORKS HOLDINGS, INC.   | 37611X209 | 06/12/2025     | Election of Class A Director: Harry E. Sloan                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             | DIRECTOR ELECTIONS                            |          16395 |                0 | AGAINST     |                                    16395 | AGAINST                     |  |
| GINKGO BIOWORKS HOLDINGS, INC.   | 37611X209 | 06/12/2025     | Ratification of the appointment of Deloitte  Touche LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2025.                                                                                                                                                                                                                                                                                                                                                                                                                               | AUDIT-RELATED                                 |          16395 |                0 | FOR         |                                    16395 | FOR                         |  |
| GINKGO BIOWORKS HOLDINGS, INC.   | 37611X209 | 06/12/2025     | Advisory vote to approve executive compensation.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         | SECTION 14A SAY-ON-PAY VOTES                  |          16395 |                0 | FOR         |                                    16395 | FOR                         |  |
| HUTCHMED CHINA LIMITED           | 44842L103 | 03/31/2025     | To approve the transactions related to the sale and purchase of a total of 45% equity interest in Shanghai Hutchison Pharmaceuticals Limited under various agreements, and all actions by the Company and/or its subsidiaries pursuant or incidental to such transactions as detailed in the notice of the Meeting.                                                                                                                                                                                                                                                                      | EXTRAORDINARY TRANSACTIONS                    |          10131 |                0 | FOR         |                                    10131 | FOR                         |  |
| HUTCHMED CHINA LIMITED           | 44842L103 | 05/13/2025     | To consider and adopt the audited Financial Statements, and the Reports of the Directors and the Independent Auditors for the year ended December 31, 2024.                                                                                                                                                                                                                                                                                                                                                                                                                              | OTHER                                         |           8414 |                0 | FOR         |                                     8414 | FOR                         |  |
| HUTCHMED CHINA LIMITED           | 44842L103 | 05/13/2025     | To re-elect Dr Dan ELDAR as a Director.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  | DIRECTOR ELECTIONS                            |           8414 |                0 | FOR         |                                     8414 | FOR                         |  |
| HUTCHMED CHINA LIMITED           | 44842L103 | 05/13/2025     | To re-elect Dr Weiguo SU as a Director.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  | DIRECTOR ELECTIONS                            |           8414 |                0 | FOR         |                                     8414 | FOR                         |  |
| HUTCHMED CHINA LIMITED           | 44842L103 | 05/13/2025     | To re-elect Mr CHENG Chig Fung, Johnny as a Director.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    | DIRECTOR ELECTIONS                            |           8414 |                0 | FOR         |                                     8414 | FOR                         |  |
| HUTCHMED CHINA LIMITED           | 44842L103 | 05/13/2025     | To re-elect Ms Edith SHIH as a Director.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 | DIRECTOR ELECTIONS                            |           8414 |                0 | FOR         |                                     8414 | FOR                         |  |
| HUTCHMED CHINA LIMITED           | 44842L103 | 05/13/2025     | To re-elect Ms Ling YANG as a Director.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  | DIRECTOR ELECTIONS                            |           8414 |                0 | FOR         |                                     8414 | FOR                         |  |
| HUTCHMED CHINA LIMITED           | 44842L103 | 05/13/2025     | To re-elect Dr Renu BHATIA as a Director.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                | DIRECTOR ELECTIONS                            |           8414 |                0 | FOR         |                                     8414 | FOR                         |  |
| HUTCHMED CHINA LIMITED           | 44842L103 | 05/13/2025     | To re-elect Dr Chaohong HU as a Director.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                | DIRECTOR ELECTIONS                            |           8414 |                0 | FOR         |                                     8414 | FOR                         |  |
| HUTCHMED CHINA LIMITED           | 44842L103 | 05/13/2025     | To re-elect Professor MOK Shu Kam, Tony as a Director.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   | DIRECTOR ELECTIONS                            |           8414 |                0 | FOR         |                                     8414 | FOR                         |  |
| HUTCHMED CHINA LIMITED           | 44842L103 | 05/13/2025     | To re-elect Mr WONG Tak Wai as a Director.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               | DIRECTOR ELECTIONS                            |           8414 |                0 | FOR         |                                     8414 | FOR                         |  |
| HUTCHMED CHINA LIMITED           | 44842L103 | 05/13/2025     | To re-appoint PricewaterhouseCoopers and PricewaterhouseCoopers Zhong Tian LLP as the Auditors of the Company for Hong Kong financial reporting and US financial reporting purposes, respectively, and to authorize the Directors to fix the Auditors' remuneration.                                                                                                                                                                                                                                                                                                                     | AUDIT-RELATED                                 |           8414 |                0 | FOR         |                                     8414 | FOR                         |  |
| HUTCHMED CHINA LIMITED           | 44842L103 | 05/13/2025     | To grant a general mandate to the Directors to issue additional shares of the Company. (Special Resolution)                                                                                                                                                                                                                                                                                                                                                                                                                                                                              | CAPITAL STRUCTURE                             |           8414 |                0 | FOR         |                                     8414 | FOR                         |  |
| HUTCHMED CHINA LIMITED           | 44842L103 | 05/13/2025     | To grant a general mandate to the Directors to repurchase shares of the Company.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         | CAPITAL STRUCTURE                             |           8414 |                0 | FOR         |                                     8414 | FOR                         |  |
| IDEAYA BIOSCIENCES, INC.         | 45166A102 | 06/24/2025     | Election of Class III Director to hold office until the 2028 annual meeting of stockholders or until their successors are elected: Jeffery L. Stein, Ph.D.                                                                                                                                                                                                                                                                                                                                                                                                                               | DIRECTOR ELECTIONS                            |           6659 |                0 | FOR         |                                     6659 | FOR                         |  |
| IDEAYA BIOSCIENCES, INC.         | 45166A102 | 06/24/2025     | Election of Class III Director to hold office until the 2028 annual meeting of stockholders or until their successors are elected: Scott W. Morrison                                                                                                                                                                                                                                                                                                                                                                                                                                     | DIRECTOR ELECTIONS                            |           6659 |                0 | WITHHOLD    |                                     6659 | AGAINST                     |  |
| IDEAYA BIOSCIENCES, INC.         | 45166A102 | 06/24/2025     | To ratify the selection, by the Audit Committee of the Company's Board of Directors, of PricewaterhouseCoopers LLP, as the independent registered public accounting firm of the Company for its fiscal year ending December 31, 2025.                                                                                                                                                                                                                                                                                                                                                    | AUDIT-RELATED                                 |           6659 |                0 | FOR         |                                     6659 | FOR                         |  |
| IDEAYA BIOSCIENCES, INC.         | 45166A102 | 06/24/2025     | To approve, on a non-binding, advisory basis, the compensation of the Company's named executive officers as disclosed in the Proxy Statement accompanying this Notice of Annual Meeting of Stockholders.                                                                                                                                                                                                                                                                                                                                                                                 | SECTION 14A SAY-ON-PAY VOTES                  |           6659 |                0 | FOR         |                                     6659 | FOR                         |  |
| IMMUNITYBIO, INC.                | 45256X103 | 06/18/2025     | Election of Director: Patrick Soon-Shiong, M.D.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          | DIRECTOR ELECTIONS                            |          43776 |                0 | WITHHOLD    |                                    43776 | AGAINST                     |  |
| IMMUNITYBIO, INC.                | 45256X103 | 06/18/2025     | Election of Director: Cheryl L. Cohen                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    | DIRECTOR ELECTIONS                            |          43776 |                0 | FOR         |                                    43776 | FOR                         |  |
| IMMUNITYBIO, INC.                | 45256X103 | 06/18/2025     | Election of Director: Richard Adcock                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     | DIRECTOR ELECTIONS                            |          43776 |                0 | FOR         |                                    43776 | FOR                         |  |
| IMMUNITYBIO, INC.                | 45256X103 | 06/18/2025     | Election of Director: Michael D. Blaszyk                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 | DIRECTOR ELECTIONS                            |          43776 |                0 | FOR         |                                    43776 | FOR                         |  |
| IMMUNITYBIO, INC.                | 45256X103 | 06/18/2025     | Election of Director: Wesley Clark                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       | DIRECTOR ELECTIONS                            |          43776 |                0 | FOR         |                                    43776 | FOR                         |  |
| IMMUNITYBIO, INC.                | 45256X103 | 06/18/2025     | Election of Director: Linda Maxwell, M.D.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                | DIRECTOR ELECTIONS                            |          43776 |                0 | FOR         |                                    43776 | FOR                         |  |
| IMMUNITYBIO, INC.                | 45256X103 | 06/18/2025     | Election of Director: Christobel Selecky                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 | DIRECTOR ELECTIONS                            |          43776 |                0 | FOR         |                                    43776 | FOR                         |  |
| IMMUNITYBIO, INC.                | 45256X103 | 06/18/2025     | Election of Director: Barry J. Simon, M.D.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               | DIRECTOR ELECTIONS                            |          43776 |                0 | FOR         |                                    43776 | FOR                         |  |
| IMMUNITYBIO, INC.                | 45256X103 | 06/18/2025     | To approve the ImmunityBio, Inc. 2025 Equity Incentive Plan.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             | COMPENSATION                                  |          43776 |                0 | AGAINST     |                                    43776 | AGAINST                     |  |
| IMMUNITYBIO, INC.                | 45256X103 | 06/18/2025     | To ratify the selection of Deloitte  Touche LLP as ImmunityBio's independent registered public accounting firm for the fiscal year ending December 31, 2025.                                                                                                                                                                                                                                                                                                                                                                                                                             | AUDIT-RELATED                                 |          43776 |                0 | FOR         |                                    43776 | FOR                         |  |
| IMMUNOCORE HOLDINGS PLC          | 45258D105 | 05/15/2025     | To re-appoint as a director Roy S. Herbst, M.D., Ph.D., who retires in accordance with the articles of association. Roy S. Herbst, M.D., Ph.D.                                                                                                                                                                                                                                                                                                                                                                                                                                           | DIRECTOR ELECTIONS                            |           4770 |                0 | AGAINST     |                                     4770 | AGAINST                     |  |
| IMMUNOCORE HOLDINGS PLC          | 45258D105 | 05/15/2025     | To re-appoint as a director Ranjeev Krishana, who retires in accordance with the articles of association. Ranjeev Krishana                                                                                                                                                                                                                                                                                                                                                                                                                                                               | DIRECTOR ELECTIONS                            |           4770 |                0 | FOR         |                                     4770 | FOR                         |  |
| IMMUNOCORE HOLDINGS PLC          | 45258D105 | 05/15/2025     | To re-appoint as a director Professor Sir Peter Ratcliffe, who retires in accordance with the articles of association. Professor Sir Peter Ratcliffe                                                                                                                                                                                                                                                                                                                                                                                                                                     | DIRECTOR ELECTIONS                            |           4770 |                0 | AGAINST     |                                     4770 | AGAINST                     |  |
| IMMUNOCORE HOLDINGS PLC          | 45258D105 | 05/15/2025     | To approve, on advisory basis, the compensation of the Company's named executive officers, as disclosed in the proxy statement.                                                                                                                                                                                                                                                                                                                                                                                                                                                          | SECTION 14A SAY-ON-PAY VOTES                  |           4770 |                0 | AGAINST     |                                     4770 | AGAINST                     |  |
| IMMUNOCORE HOLDINGS PLC          | 45258D105 | 05/15/2025     | To ratify the appointment of Deloitte LLP, a limited liability partnership organized under the laws of England, as our U.S. independent registered public accounting firm for the year ending 31 December 2025.                                                                                                                                                                                                                                                                                                                                                                          | AUDIT-RELATED                                 |           4770 |                0 | FOR         |                                     4770 | FOR                         |  |
| IMMUNOCORE HOLDINGS PLC          | 45258D105 | 05/15/2025     | To re-appoint Deloitte LLP, a limited liability partnership organized under the laws of England, as our U.K. statutory auditors, to hold office until the conclusion of our next annual general meeting of shareholders.                                                                                                                                                                                                                                                                                                                                                                 | AUDIT-RELATED                                 |           4770 |                0 | FOR         |                                     4770 | FOR                         |  |
| IMMUNOCORE HOLDINGS PLC          | 45258D105 | 05/15/2025     | To authorize the audit committee to determine the U.K. statutory auditors' remuneration for the year ending 31 December 2025.                                                                                                                                                                                                                                                                                                                                                                                                                                                            | AUDIT-RELATED                                 |           4770 |                0 | FOR         |                                     4770 | FOR                         |  |
| IMMUNOCORE HOLDINGS PLC          | 45258D105 | 05/15/2025     | To receive and adopt the U.K. statutory annual accounts and reports for the year ended 31 December 2024.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 | OTHER                                         |           4770 |                0 | FOR         |                                     4770 | FOR                         |  |
| IMMUNOCORE HOLDINGS PLC          | 45258D105 | 05/15/2025     | To approve the directors' remuneration report for the year ended 31 December 2024, which is set forth as Annex A to the proxy statement (excluding the directors' remuneration policy set out on pages A-5 to A-15 of Annex A to the proxy statement).                                                                                                                                                                                                                                                                                                                                   | COMPENSATION                                  |           4770 |                0 | AGAINST     |                                     4770 | AGAINST                     |  |
| IMMUNOCORE HOLDINGS PLC          | 45258D105 | 05/15/2025     | To approve the directors' remuneration policy, which is set forth on pages A-5 to A-15 of Annex A to the proxy statement, which will take effect immediately after the end of the AGM.                                                                                                                                                                                                                                                                                                                                                                                                   | COMPENSATION; CORPORATE GOVERNANCE            |           4770 |                0 | AGAINST     |                                     4770 | AGAINST                     |  |
| IMMUNOCORE HOLDINGS PLC          | 45258D105 | 05/15/2025     | To authorize the Company to make political donations/incur political expenditure.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        | OTHER SOCIAL ISSUES                           |           4770 |                0 | FOR         |                                     4770 | FOR                         |  |
| IMMUNOCORE HOLDINGS PLC          | 45258D105 | 05/15/2025     | To authorize the directors to allot shares or to grant rights to subscribe for or convert any security into shares up to an aggregate nominal amount of £150,000.                                                                                                                                                                                                                                                                                                                                                                                                                        | CAPITAL STRUCTURE                             |           4770 |                0 | AGAINST     |                                     4770 | AGAINST                     |  |
| IMMUNOCORE HOLDINGS PLC          | 45258D105 | 05/15/2025     | To empower the directors to allot equity securities for cash pursuant to the authorization in resolution 12 as if U.K. statutory pre-emption rights did not apply.                                                                                                                                                                                                                                                                                                                                                                                                                       | CAPITAL STRUCTURE                             |           4770 |                0 | AGAINST     |                                     4770 | AGAINST                     |  |
| INHIBRX BIOSCIENCES, INC.        | 45720N103 | 05/28/2025     | Election of Class I Director to serve until our 2028 Annual Meeting of Stockholders and until their respective successors are duly elected and qualified, or until their respective earlier death, resignation, or removal: Jon Faiz Kayyem, Ph.D.                                                                                                                                                                                                                                                                                                                                       | DIRECTOR ELECTIONS                            |           9138 |                0 | FOR         |                                     9138 | FOR                         |  |
| INHIBRX BIOSCIENCES, INC.        | 45720N103 | 05/28/2025     | Election of Class I Director to serve until our 2028 Annual Meeting of Stockholders and until their respective successors are duly elected and qualified, or until their respective earlier death, resignation, or removal: Kristiina Vuori, M.D., Ph.D.                                                                                                                                                                                                                                                                                                                                 | DIRECTOR ELECTIONS                            |           9138 |                0 | WITHHOLD    |                                     9138 | AGAINST                     |  |
| INHIBRX BIOSCIENCES, INC.        | 45720N103 | 05/28/2025     | To ratify the appointment of BDO USA, P.C. as our independent registered public accounting firm for the fiscal year ending December 31, 2025.                                                                                                                                                                                                                                                                                                                                                                                                                                            | AUDIT-RELATED                                 |           9138 |                0 | FOR         |                                     9138 | FOR                         |  |
| INNATE PHARMA S A                | 45781K204 | 05/22/2025     | Please see Exhibit A of the Depositary Notice for agenda items.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          | OTHER                                         |          62752 |                0 | FOR         |                                    62752 | FOR                         |  |
| INNATE PHARMA S A                | 45781K204 | 05/22/2025     | Please see Exhibit A of the Depositary Notice for agenda items.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          | OTHER                                         |          62752 |                0 | FOR         |                                    62752 | FOR                         |  |
| INNATE PHARMA S A                | 45781K204 | 05/22/2025     | Please see Exhibit A of the Depositary Notice for agenda items.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          | CAPITAL STRUCTURE                             |          62752 |                0 | FOR         |                                    62752 | FOR                         |  |
| INNATE PHARMA S A                | 45781K204 | 05/22/2025     | Please see Exhibit A of the Depositary Notice for agenda items.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          | OTHER                                         |          62752 |                0 | AGAINST     |                                    62752 | AGAINST                     |  |
| INNATE PHARMA S A                | 45781K204 | 05/22/2025     | Please see Exhibit A of the Depositary Notice for agenda items.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          | COMPENSATION                                  |          62752 |                0 | FOR         |                                    62752 | FOR                         |  |
| INNATE PHARMA S A                | 45781K204 | 05/22/2025     | Please see Exhibit A of the Depositary Notice for agenda items.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          | SECTION 14A SAY-ON-PAY VOTES                  |          62752 |                0 | AGAINST     |                                    62752 | AGAINST                     |  |
| INNATE PHARMA S A                | 45781K204 | 05/22/2025     | Please see Exhibit A of the Depositary Notice for agenda items.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          | SECTION 14A SAY-ON-PAY VOTES                  |          62752 |                0 | AGAINST     |                                    62752 | AGAINST                     |  |
| INNATE PHARMA S A                | 45781K204 | 05/22/2025     | Please see Exhibit A of the Depositary Notice for agenda items.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          | SECTION 14A SAY-ON-PAY VOTES                  |          62752 |                0 | FOR         |                                    62752 | FOR                         |  |
| INNATE PHARMA S A                | 45781K204 | 05/22/2025     | Please see Exhibit A of the Depositary Notice for agenda items.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          | OTHER                                         |          62752 |                0 | FOR         |                                    62752 | FOR                         |  |
| INNATE PHARMA S A                | 45781K204 | 05/22/2025     | Please see Exhibit A of the Depositary Notice for agenda items.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          | CORPORATE GOVERNANCE                          |          62752 |                0 | FOR         |                                    62752 | FOR                         |  |
| INNATE PHARMA S A                | 45781K204 | 05/22/2025     | Please see Exhibit A of the Depositary Notice for agenda items.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          | DIRECTOR ELECTIONS                            |          62752 |                0 | FOR         |                                    62752 | FOR                         |  |
| INNATE PHARMA S A                | 45781K204 | 05/22/2025     | Please see Exhibit A of the Depositary Notice for agenda items.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          | DIRECTOR ELECTIONS                            |          62752 |                0 | AGAINST     |                                    62752 | AGAINST                     |  |
| INNATE PHARMA S A                | 45781K204 | 05/22/2025     | Please see Exhibit A of the Depositary Notice for agenda items.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          | DIRECTOR ELECTIONS                            |          62752 |                0 | AGAINST     |                                    62752 | AGAINST                     |  |
| INNATE PHARMA S A                | 45781K204 | 05/22/2025     | Please see Exhibit A of the Depositary Notice for agenda items.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          | DIRECTOR ELECTIONS                            |          62752 |                0 | AGAINST     |                                    62752 | AGAINST                     |  |
| INNATE PHARMA S A                | 45781K204 | 05/22/2025     | Please see Exhibit A of the Depositary Notice for agenda items.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          | DIRECTOR ELECTIONS                            |          62752 |                0 | FOR         |                                    62752 | FOR                         |  |
| INNATE PHARMA S A                | 45781K204 | 05/22/2025     | Please see Exhibit A of the Depositary Notice for agenda items.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          | DIRECTOR ELECTIONS                            |          62752 |                0 | FOR         |                                    62752 | FOR                         |  |
| INNATE PHARMA S A                | 45781K204 | 05/22/2025     | Please see Exhibit A of the Depositary Notice for agenda items.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          | DIRECTOR ELECTIONS                            |          62752 |                0 | AGAINST     |                                    62752 | AGAINST                     |  |
| INNATE PHARMA S A                | 45781K204 | 05/22/2025     | Please see Exhibit A of the Depositary Notice for agenda items.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          | DIRECTOR ELECTIONS                            |          62752 |                0 | AGAINST     |                                    62752 | AGAINST                     |  |
| INNATE PHARMA S A                | 45781K204 | 05/22/2025     | Please see Exhibit A of the Depositary Notice for agenda items.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          | COMPENSATION; CORPORATE GOVERNANCE            |          62752 |                0 | AGAINST     |                                    62752 | AGAINST                     |  |
| INNATE PHARMA S A                | 45781K204 | 05/22/2025     | Please see Exhibit A of the Depositary Notice for agenda items.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          | COMPENSATION; CORPORATE GOVERNANCE            |          62752 |                0 | FOR         |                                    62752 | FOR                         |  |
| INNATE PHARMA S A                | 45781K204 | 05/22/2025     | Please see Exhibit A of the Depositary Notice for agenda items.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          | COMPENSATION; CORPORATE GOVERNANCE            |          62752 |                0 | FOR         |                                    62752 | FOR                         |  |
| INNATE PHARMA S A                | 45781K204 | 05/22/2025     | Please see Exhibit A of the Depositary Notice for agenda items.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          | COMPENSATION; CORPORATE GOVERNANCE            |          62752 |                0 | FOR         |                                    62752 | FOR                         |  |
| INNATE PHARMA S A                | 45781K204 | 05/22/2025     | Please see Exhibit A of the Depositary Notice for agenda items.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          | COMPENSATION                                  |          62752 |                0 | FOR         |                                    62752 | FOR                         |  |
| INNATE PHARMA S A                | 45781K204 | 05/22/2025     | Please see Exhibit A of the Depositary Notice for agenda items.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          | CAPITAL STRUCTURE                             |          62752 |                0 | FOR         |                                    62752 | FOR                         |  |
| INNATE PHARMA S A                | 45781K204 | 05/22/2025     | Please see Exhibit A of the Depositary Notice for agenda items.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          | DIRECTOR ELECTIONS                            |          62752 |                0 | AGAINST     |                                    62752 | AGAINST                     |  |
| INNATE PHARMA S A                | 45781K204 | 05/22/2025     | Please see Exhibit A of the Depositary Notice for agenda items.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          | DIRECTOR ELECTIONS                            |          62752 |                0 | FOR         |                                    62752 | FOR                         |  |
| INNATE PHARMA S A                | 45781K204 | 05/22/2025     | Please see Exhibit A of the Depositary Notice for agenda items.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          | DIRECTOR ELECTIONS                            |          62752 |                0 | AGAINST     |                                    62752 | AGAINST                     |  |
| INNATE PHARMA S A                | 45781K204 | 05/22/2025     | Please see Exhibit A of the Depositary Notice for agenda items.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          | DIRECTOR ELECTIONS                            |          62752 |                0 | AGAINST     |                                    62752 | AGAINST                     |  |
| INNATE PHARMA S A                | 45781K204 | 05/22/2025     | Please see Exhibit A of the Depositary Notice for agenda items.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          | DIRECTOR ELECTIONS                            |          62752 |                0 | AGAINST     |                                    62752 | AGAINST                     |  |
| INNATE PHARMA S A                | 45781K204 | 05/22/2025     | Please see Exhibit A of the Depositary Notice for agenda items.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          | COMPENSATION; CORPORATE GOVERNANCE            |          62752 |                0 | AGAINST     |                                    62752 | AGAINST                     |  |
| INNATE PHARMA S A                | 45781K204 | 05/22/2025     | Please see Exhibit A of the Depositary Notice for agenda items.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          | COMPENSATION; CORPORATE GOVERNANCE            |          62752 |                0 | FOR         |                                    62752 | FOR                         |  |
| INNATE PHARMA S A                | 45781K204 | 05/22/2025     | Please see Exhibit A of the Depositary Notice for agenda items.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          | COMPENSATION; CORPORATE GOVERNANCE            |          62752 |                0 | AGAINST     |                                    62752 | AGAINST                     |  |
| INNATE PHARMA S A                | 45781K204 | 05/22/2025     | Please see Exhibit A of the Depositary Notice for agenda items.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          | COMPENSATION; CORPORATE GOVERNANCE            |          62752 |                0 | FOR         |                                    62752 | FOR                         |  |
| INNATE PHARMA S A                | 45781K204 | 05/22/2025     | Please see Exhibit A of the Depositary Notice for agenda items.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          | COMPENSATION; CORPORATE GOVERNANCE            |          62752 |                0 | FOR         |                                    62752 | FOR                         |  |
| INNATE PHARMA S A                | 45781K204 | 05/22/2025     | Please see Exhibit A of the Depositary Notice for agenda items.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          | COMPENSATION                                  |          62752 |                0 | FOR         |                                    62752 | FOR                         |  |
| INNATE PHARMA S A                | 45781K204 | 05/22/2025     | Please see Exhibit A of the Depositary Notice for agenda items.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          | CAPITAL STRUCTURE                             |          62752 |                0 | FOR         |                                    62752 | FOR                         |  |
| INNATE PHARMA S A                | 45781K204 | 05/22/2025     | Please see Exhibit A of the Depositary Notice for agenda items.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          | CAPITAL STRUCTURE                             |          62752 |                0 | AGAINST     |                                    62752 | AGAINST                     |  |
| INNATE PHARMA S A                | 45781K204 | 05/22/2025     | Please see Exhibit A of the Depositary Notice for agenda items.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          | CAPITAL STRUCTURE                             |          62752 |                0 | AGAINST     |                                    62752 | AGAINST                     |  |
| INNATE PHARMA S A                | 45781K204 | 05/22/2025     | Please see Exhibit A of the Depositary Notice for agenda items.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          | CAPITAL STRUCTURE                             |          62752 |                0 | AGAINST     |                                    62752 | AGAINST                     |  |
| INNATE PHARMA S A                | 45781K204 | 05/22/2025     | Please see Exhibit A of the Depositary Notice for agenda items.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          | CAPITAL STRUCTURE                             |          62752 |                0 | AGAINST     |                                    62752 | AGAINST                     |  |
| INNATE PHARMA S A                | 45781K204 | 05/22/2025     | Please see Exhibit A of the Depositary Notice for agenda items.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          | CAPITAL STRUCTURE                             |          62752 |                0 | AGAINST     |                                    62752 | AGAINST                     |  |
| INNATE PHARMA S A                | 45781K204 | 05/22/2025     | Please see Exhibit A of the Depositary Notice for agenda items.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          | CAPITAL STRUCTURE                             |          62752 |                0 | AGAINST     |                                    62752 | AGAINST                     |  |
| INNATE PHARMA S A                | 45781K204 | 05/22/2025     | Please see Exhibit A of the Depositary Notice for agenda items.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          | CAPITAL STRUCTURE                             |          62752 |                0 | AGAINST     |                                    62752 | AGAINST                     |  |
| INNATE PHARMA S A                | 45781K204 | 05/22/2025     | Please see Exhibit A of the Depositary Notice for agenda items.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          | CAPITAL STRUCTURE                             |          62752 |                0 | AGAINST     |                                    62752 | AGAINST                     |  |
| INNATE PHARMA S A                | 45781K204 | 05/22/2025     | Please see Exhibit A of the Depositary Notice for agenda items.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          | CAPITAL STRUCTURE                             |          62752 |                0 | FOR         |                                    62752 | FOR                         |  |
| INNATE PHARMA S A                | 45781K204 | 05/22/2025     | Please see Exhibit A of the Depositary Notice for agenda items.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          | COMPENSATION                                  |          62752 |                0 | FOR         |                                    62752 | FOR                         |  |
| INNATE PHARMA S A                | 45781K204 | 05/22/2025     | Please see Exhibit A of the Depositary Notice for agenda items.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          | COMPENSATION                                  |          62752 |                0 | FOR         |                                    62752 | FOR                         |  |
| INNATE PHARMA S A                | 45781K204 | 05/22/2025     | Please see Exhibit A of the Depositary Notice for agenda items.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          | COMPENSATION                                  |          62752 |                0 | AGAINST     |                                    62752 | AGAINST                     |  |
| INNATE PHARMA S A                | 45781K204 | 05/22/2025     | Please see Exhibit A of the Depositary Notice for agenda items.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          | COMPENSATION                                  |          62752 |                0 | AGAINST     |                                    62752 | AGAINST                     |  |
| INNATE PHARMA S A                | 45781K204 | 05/22/2025     | Please see Exhibit A of the Depositary Notice for agenda items.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          | COMPENSATION                                  |          62752 |                0 | AGAINST     |                                    62752 | AGAINST                     |  |
| INNATE PHARMA S A                | 45781K204 | 05/22/2025     | Please see Exhibit A of the Depositary Notice for agenda items.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          | CAPITAL STRUCTURE                             |          62752 |                0 | FOR         |                                    62752 | FOR                         |  |
| INNATE PHARMA S A                | 45781K204 | 05/22/2025     | Please see Exhibit A of the Depositary Notice for agenda items.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          | COMPENSATION                                  |          62752 |                0 | AGAINST     |                                    62752 | AGAINST                     |  |
| INNATE PHARMA S A                | 45781K204 | 05/22/2025     | Please see Exhibit A of the Depositary Notice for agenda items.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          | CAPITAL STRUCTURE                             |          62752 |                0 | FOR         |                                    62752 | FOR                         |  |
| INNATE PHARMA S A                | 45781K204 | 05/22/2025     | Please see Exhibit A of the Depositary Notice for agenda items.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          | CAPITAL STRUCTURE                             |          62752 |                0 | AGAINST     |                                    62752 | AGAINST                     |  |
| INNATE PHARMA S A                | 45781K204 | 05/22/2025     | Please see Exhibit A of the Depositary Notice for agenda items.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          | CAPITAL STRUCTURE                             |          62752 |                0 | AGAINST     |                                    62752 | AGAINST                     |  |
| INNATE PHARMA S A                | 45781K204 | 05/22/2025     | Please see Exhibit A of the Depositary Notice for agenda items.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          | CAPITAL STRUCTURE                             |          62752 |                0 | AGAINST     |                                    62752 | AGAINST                     |  |
| INNATE PHARMA S A                | 45781K204 | 05/22/2025     | Please see Exhibit A of the Depositary Notice for agenda items.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          | CAPITAL STRUCTURE                             |          62752 |                0 | AGAINST     |                                    62752 | AGAINST                     |  |
| INNATE PHARMA S A                | 45781K204 | 05/22/2025     | Please see Exhibit A of the Depositary Notice for agenda items.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          | CAPITAL STRUCTURE                             |          62752 |                0 | AGAINST     |                                    62752 | AGAINST                     |  |
| INNATE PHARMA S A                | 45781K204 | 05/22/2025     | Please see Exhibit A of the Depositary Notice for agenda items.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          | CAPITAL STRUCTURE                             |          62752 |                0 | AGAINST     |                                    62752 | AGAINST                     |  |
| INNATE PHARMA S A                | 45781K204 | 05/22/2025     | Please see Exhibit A of the Depositary Notice for agenda items.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          | CAPITAL STRUCTURE                             |          62752 |                0 | AGAINST     |                                    62752 | AGAINST                     |  |
| INNATE PHARMA S A                | 45781K204 | 05/22/2025     | Please see Exhibit A of the Depositary Notice for agenda items.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          | CAPITAL STRUCTURE                             |          62752 |                0 | AGAINST     |                                    62752 | AGAINST                     |  |
| INNATE PHARMA S A                | 45781K204 | 05/22/2025     | Please see Exhibit A of the Depositary Notice for agenda items.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          | CAPITAL STRUCTURE                             |          62752 |                0 | FOR         |                                    62752 | FOR                         |  |
| INNATE PHARMA S A                | 45781K204 | 05/22/2025     | Please see Exhibit A of the Depositary Notice for agenda items.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          | COMPENSATION                                  |          62752 |                0 | FOR         |                                    62752 | FOR                         |  |
| INNATE PHARMA S A                | 45781K204 | 05/22/2025     | Please see Exhibit A of the Depositary Notice for agenda items.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          | COMPENSATION                                  |          62752 |                0 | FOR         |                                    62752 | FOR                         |  |
| INNATE PHARMA S A                | 45781K204 | 05/22/2025     | Please see Exhibit A of the Depositary Notice for agenda items.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          | COMPENSATION                                  |          62752 |                0 | AGAINST     |                                    62752 | AGAINST                     |  |
| INNATE PHARMA S A                | 45781K204 | 05/22/2025     | Please see Exhibit A of the Depositary Notice for agenda items.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          | COMPENSATION                                  |          62752 |                0 | AGAINST     |                                    62752 | AGAINST                     |  |
| INNATE PHARMA S A                | 45781K204 | 05/22/2025     | Please see Exhibit A of the Depositary Notice for agenda items.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          | COMPENSATION                                  |          62752 |                0 | AGAINST     |                                    62752 | AGAINST                     |  |
| INNATE PHARMA S A                | 45781K204 | 05/22/2025     | Please see Exhibit A of the Depositary Notice for agenda items.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          | CAPITAL STRUCTURE                             |          62752 |                0 | FOR         |                                    62752 | FOR                         |  |
| INNATE PHARMA S A                | 45781K204 | 05/22/2025     | Please see Exhibit A of the Depositary Notice for agenda items.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          | COMPENSATION                                  |          62752 |                0 | AGAINST     |                                    62752 | AGAINST                     |  |
| INNATE PHARMA S A                | 45781K204 | 05/22/2025     | Please see Exhibit A of the Depositary Notice for agenda items.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          | CAPITAL STRUCTURE                             |          62752 |                0 | FOR         |                                    62752 | FOR                         |  |
| INNATE PHARMA S A                | 45781K204 | 05/22/2025     | Please see Exhibit A of the Depositary Notice for agenda items.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          | CORPORATE GOVERNANCE                          |          62752 |                0 | AGAINST     |                                    62752 | AGAINST                     |  |
| INNATE PHARMA S A                | 45781K204 | 05/22/2025     | Please see Exhibit A of the Depositary Notice for agenda items.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          | CORPORATE GOVERNANCE                          |          62752 |                0 | AGAINST     |                                    62752 | AGAINST                     |  |
| INNATE PHARMA S A                | 45781K204 | 05/22/2025     | Please see Exhibit A of the Depositary Notice for agenda items.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          | OTHER                                         |          62752 |                0 | FOR         |                                    62752 | FOR                         |  |
| IOVANCE BIOTHERAPEUTICS, INC.    | 462260100 | 06/10/2025     | Election of Director to serve until the 2026 Annual Meeting of Stockholders: Iain Dukes, D. Phil.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        | DIRECTOR ELECTIONS                            |          34061 |                0 | FOR         |                                    34061 | FOR                         |  |
| IOVANCE BIOTHERAPEUTICS, INC.    | 462260100 | 06/10/2025     | Election of Director to serve until the 2026 Annual Meeting of Stockholders: Athena Countouriotis, M.D.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  | DIRECTOR ELECTIONS                            |          34061 |                0 | AGAINST     |                                    34061 | AGAINST                     |  |
| IOVANCE BIOTHERAPEUTICS, INC.    | 462260100 | 06/10/2025     | Election of Director to serve until the 2026 Annual Meeting of Stockholders: Ryan Maynard                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                | DIRECTOR ELECTIONS                            |          34061 |                0 | FOR         |                                    34061 | FOR                         |  |
| IOVANCE BIOTHERAPEUTICS, INC.    | 462260100 | 06/10/2025     | Election of Director to serve until the 2026 Annual Meeting of Stockholders: Wayne P. Rothbaum                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           | DIRECTOR ELECTIONS                            |          34061 |                0 | FOR         |                                    34061 | FOR                         |  |
| IOVANCE BIOTHERAPEUTICS, INC.    | 462260100 | 06/10/2025     | Election of Director to serve until the 2026 Annual Meeting of Stockholders: Frederick G. Vogt, Ph.D., J.D.                                                                                                                                                                                                                                                                                                                                                                                                                                                                              | DIRECTOR ELECTIONS                            |          34061 |                0 | FOR         |                                    34061 | FOR                         |  |
| IOVANCE BIOTHERAPEUTICS, INC.    | 462260100 | 06/10/2025     | Election of Director to serve until the 2026 Annual Meeting of Stockholders: Michael Weiser, M.D., Ph.D.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 | DIRECTOR ELECTIONS                            |          34061 |                0 | FOR         |                                    34061 | FOR                         |  |
| IOVANCE BIOTHERAPEUTICS, INC.    | 462260100 | 06/10/2025     | Election of Director to serve until the 2026 Annual Meeting of Stockholders: Wendy Yarno                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 | DIRECTOR ELECTIONS                            |          34061 |                0 | FOR         |                                    34061 | FOR                         |  |
| IOVANCE BIOTHERAPEUTICS, INC.    | 462260100 | 06/10/2025     | To approve, by non-binding advisory vote, the compensation of our named executive officers.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              | SECTION 14A SAY-ON-PAY VOTES                  |          34061 |                0 | FOR         |                                    34061 | FOR                         |  |
| IOVANCE BIOTHERAPEUTICS, INC.    | 462260100 | 06/10/2025     | To ratify the appointment of Ernst  Young LLP as our independent registered public accounting firm for our fiscal year ending December 31, 2025.                                                                                                                                                                                                                                                                                                                                                                                                                                         | AUDIT-RELATED                                 |          34061 |                0 | FOR         |                                    34061 | FOR                         |  |
| IOVANCE BIOTHERAPEUTICS, INC.    | 462260100 | 06/10/2025     | To approve an amendment to our 2018 Equity Incentive Plan to increase the number of shares of the Company's common stock authorized for issuance thereunder by 12,500,000 shares.                                                                                                                                                                                                                                                                                                                                                                                                        | COMPENSATION                                  |          34061 |                0 | FOR         |                                    34061 | FOR                         |  |
| IOVANCE BIOTHERAPEUTICS, INC.    | 462260100 | 06/10/2025     | To approve an amendment to our 2020 Employee Stock Purchase Plan to increase the number of shares of the Company's common stock authorized for issuance thereunder by 1,000,000 shares.                                                                                                                                                                                                                                                                                                                                                                                                  | CAPITAL STRUCTURE                             |          34061 |                0 | FOR         |                                    34061 | FOR                         |  |
| ITEOS THERAPEUTICS, INC.         | 46565G104 | 06/17/2025     | Election of Class II Director to serve until the 2028 Annual Meeting of Stockholders: Tony Ho                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            | DIRECTOR ELECTIONS                            |          17308 |                0 | WITHHOLD    |                                    17308 | AGAINST                     |  |
| ITEOS THERAPEUTICS, INC.         | 46565G104 | 06/17/2025     | Election of Class II Director to serve until the 2028 Annual Meeting of Stockholders: Robert Iannone                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     | DIRECTOR ELECTIONS                            |          17308 |                0 | FOR         |                                    17308 | FOR                         |  |
| ITEOS THERAPEUTICS, INC.         | 46565G104 | 06/17/2025     | Election of Class II Director to serve until the 2028 Annual Meeting of Stockholders: Ann D. Rhoads                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      | DIRECTOR ELECTIONS                            |          17308 |                0 | WITHHOLD    |                                    17308 | AGAINST                     |  |
| ITEOS THERAPEUTICS, INC.         | 46565G104 | 06/17/2025     | To ratify the appointment of Deloitte Bedrijfsrevisoren / Réviseurs d'Entreprises BV/SRL as our independent registered public accounting firm for the fiscal year ending December 31, 2025.                                                                                                                                                                                                                                                                                                                                                                                              | AUDIT-RELATED                                 |          17308 |                0 | FOR         |                                    17308 | FOR                         |  |
| JANUX THERAPEUTICS, INC.         | 47103J105 | 06/11/2025     | Election of Class I Director to serve for three-year terms until the 2028 Annual Meeting of Stockholders: Ronald Barrett, Ph.D.                                                                                                                                                                                                                                                                                                                                                                                                                                                          | DIRECTOR ELECTIONS                            |           4043 |                0 | WITHHOLD    |                                     4043 | AGAINST                     |  |
| JANUX THERAPEUTICS, INC.         | 47103J105 | 06/11/2025     | Election of Class I Director to serve for three-year terms until the 2028 Annual Meeting of Stockholders: David Campbell, Ph.D.                                                                                                                                                                                                                                                                                                                                                                                                                                                          | DIRECTOR ELECTIONS                            |           4043 |                0 | WITHHOLD    |                                     4043 | AGAINST                     |  |
| JANUX THERAPEUTICS, INC.         | 47103J105 | 06/11/2025     | Election of Class I Director to serve for three-year terms until the 2028 Annual Meeting of Stockholders: Winston Kung                                                                                                                                                                                                                                                                                                                                                                                                                                                                   | DIRECTOR ELECTIONS                            |           4043 |                0 | WITHHOLD    |                                     4043 | AGAINST                     |  |
| JANUX THERAPEUTICS, INC.         | 47103J105 | 06/11/2025     | To ratify the selection by the Audit Committee of the Board of Directors of Ernst  Young LLP as our independent registered public accounting firm for our fiscal year ending December 31, 2025.                                                                                                                                                                                                                                                                                                                                                                                          | AUDIT-RELATED                                 |           4043 |                0 | FOR         |                                     4043 | FOR                         |  |
| JANUX THERAPEUTICS, INC.         | 47103J105 | 06/11/2025     | Approval, on an advisory basis, of the compensation of our named executive officers ("Say-On-Pay"), as disclosed in the accompanying Proxy Statement.                                                                                                                                                                                                                                                                                                                                                                                                                                    | SECTION 14A SAY-ON-PAY VOTES                  |           4043 |                0 | FOR         |                                     4043 | FOR                         |  |
| JANUX THERAPEUTICS, INC.         | 47103J105 | 06/11/2025     | Indication, on an advisory basis, of the preferred frequency of holding future Say-On-Pay votes on the compensation of our named executive officers.                                                                                                                                                                                                                                                                                                                                                                                                                                     | SECTION 14A SAY-ON-PAY VOTES                  |           4043 |                0 | 1 YEAR      |                                     4043 | FOR                         |  |
| KARYOPHARM THERAPEUTICS INC.     | 48576U106 | 01/30/2025     | To adopt and approve an amendment to the Karyopharm Therapeutics Inc. Restated Certificate of Incorporation, as amended, to increase the number of authorized shares of our capital stock from 405,000,000 to 805,000,000 and the number of authorized shares of our common stock from 400,000,000 to 800,000,000.                                                                                                                                                                                                                                                                       | CAPITAL STRUCTURE                             |         218791 |                0 | FOR         |                                   218791 | FOR                         |  |
| KARYOPHARM THERAPEUTICS INC.     | 48576U106 | 01/30/2025     | To adopt and approve an amendment to the Karyopharm Therapeutics Inc. Restated Certificate of Inc, as amended, to effect a reverse stock split of our issued shares of common stock at a ratio within the range of not less than 1-for-5 and not greater than 1-for-15, and a proportionate reduction in the number of authorized shares of common stock, with the exact ratio within such range and the implementation  timing of such reverse stock split to be determined at sole discretion of Board of Directors, without further approval or authorization of our stockholders.    | CAPITAL STRUCTURE                             |         218791 |                0 | FOR         |                                   218791 | FOR                         |  |
| KARYOPHARM THERAPEUTICS INC.     | 48576U106 | 01/30/2025     | To approve a proposal to adjourn the Special Meeting to a later date or dates, if necessary to permit further solicitation of proxies in the event that there are insufficient votes for the adoption and approval of Proposal 1 or Proposal 2.                                                                                                                                                                                                                                                                                                                                          | CORPORATE GOVERNANCE                          |         218791 |                0 | FOR         |                                   218791 | FOR                         |  |
| KURA ONCOLOGY, INC.              | 50127T109 | 06/05/2025     | Election of Class II Director for three-year term: Helen Collins, M.D.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   | DIRECTOR ELECTIONS                            |          17474 |                0 | WITHHOLD    |                                    17474 | AGAINST                     |  |
| KURA ONCOLOGY, INC.              | 50127T109 | 06/05/2025     | Election of Class II Director for three-year term: Thomas Malley                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         | DIRECTOR ELECTIONS                            |          17474 |                0 | WITHHOLD    |                                    17474 | AGAINST                     |  |
| KURA ONCOLOGY, INC.              | 50127T109 | 06/05/2025     | Election of Class II Director for three-year term: Carol Schafer                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         | DIRECTOR ELECTIONS                            |          17474 |                0 | WITHHOLD    |                                    17474 | AGAINST                     |  |
| KURA ONCOLOGY, INC.              | 50127T109 | 06/05/2025     | Ratification of the appointment of Ernst  Young LLP as our independent registered public accounting firm for our fiscal year ending December 31, 2025.                                                                                                                                                                                                                                                                                                                                                                                                                                   | AUDIT-RELATED                                 |          17474 |                0 | FOR         |                                    17474 | FOR                         |  |
| KURA ONCOLOGY, INC.              | 50127T109 | 06/05/2025     | Approval, on an advisory basis, of the compensation of our named executive officers, as disclosed in the proxy statement.                                                                                                                                                                                                                                                                                                                                                                                                                                                                | SECTION 14A SAY-ON-PAY VOTES                  |          17474 |                0 | FOR         |                                    17474 | FOR                         |  |
| KURA ONCOLOGY, INC.              | 50127T109 | 06/05/2025     | Approval of an amendment to our Amended and Restated 2014 Equity Incentive Plan.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         | COMPENSATION                                  |          17474 |                0 | AGAINST     |                                    17474 | AGAINST                     |  |
| KYMERA THERAPEUTICS, INC.        | 501575104 | 06/25/2025     | DIRECTOR: Jeffrey Albers,J.D.,MBA                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        | DIRECTOR ELECTIONS                            |           3693 |                0 | ABSTAIN     |                                     3693 | AGAINST                     |  |
| KYMERA THERAPEUTICS, INC.        | 501575104 | 06/25/2025     | DIRECTOR: Felix J. Baker, Ph.D.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          | DIRECTOR ELECTIONS                            |           3693 |                0 | ABSTAIN     |                                     3693 | AGAINST                     |  |
| KYMERA THERAPEUTICS, INC.        | 501575104 | 06/25/2025     | To approve, on a non-binding advisory basis, the compensation of our named executive officers.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           | SECTION 14A SAY-ON-PAY VOTES                  |           3693 |                0 | FOR         |                                     3693 | FOR                         |  |
| KYMERA THERAPEUTICS, INC.        | 501575104 | 06/25/2025     | To ratify the appointment of Ernst  Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2025.                                                                                                                                                                                                                                                                                                                                                                                                                                         | AUDIT-RELATED                                 |           3693 |                0 | FOR         |                                     3693 | FOR                         |  |
| LEGEND BIOTECH CORPORATION       | 52490G102 | 10/21/2024     | To receive the audited consolidated financial statements of the Company for the fiscal year ended December 31, 2023.                                                                                                                                                                                                                                                                                                                                                                                                                                                                     | OTHER                                         |           2652 |                0 | FOR         |                                     2652 | FOR                         |  |
| LEGEND BIOTECH CORPORATION       | 52490G102 | 10/21/2024     | To ratify the appointment of Ernst  Young LLP as independent auditor of the Company (the "Independent Auditor") for the fiscal year ending December 31, 2024.                                                                                                                                                                                                                                                                                                                                                                                                                            | AUDIT-RELATED                                 |           2652 |                0 | FOR         |                                     2652 | FOR                         |  |
| LEGEND BIOTECH CORPORATION       | 52490G102 | 10/21/2024     | To re-elect Ms. Ye Wang, whose term of office will expire pursuant to article 88(b) of the Company's memorandum of association, to serve as a Class I director of the Company for a full term of three (3) years.                                                                                                                                                                                                                                                                                                                                                                        | DIRECTOR ELECTIONS                            |           2652 |                0 | AGAINST     |                                     2652 | AGAINST                     |  |
| LEGEND BIOTECH CORPORATION       | 52490G102 | 10/21/2024     | To re-elect Dr. Darren Xiaohui Ji, whose term of office will expire pursuant to article 88(b) of the Company's memorandum of association, to serve as a Class I director of the Company for a full term of three (3) years.                                                                                                                                                                                                                                                                                                                                                              | DIRECTOR ELECTIONS                            |           2652 |                0 | FOR         |                                     2652 | FOR                         |  |
| LEGEND BIOTECH CORPORATION       | 52490G102 | 10/21/2024     | To re-elect Dr. Ying Huang, whose term of office will expire pursuant to article 88(b) of the Company's memorandum of association, to serve as a Class I director of the Company for a full term of three (3) years.                                                                                                                                                                                                                                                                                                                                                                     | DIRECTOR ELECTIONS                            |           2652 |                0 | FOR         |                                     2652 | FOR                         |  |
| LEGEND BIOTECH CORPORATION       | 52490G102 | 10/21/2024     | To re-elect Tomas Heyman, whose term of office will expire pursuant to article 88(b) of the Company's memorandum of association, to serve as a Class I director of the Company for a full term of three (3) years.                                                                                                                                                                                                                                                                                                                                                                       | DIRECTOR ELECTIONS                            |           2652 |                0 | FOR         |                                     2652 | FOR                         |  |
| LEGEND BIOTECH CORPORATION       | 52490G102 | 10/21/2024     | To approve an amendment and restatement of the Company's 2020 Restricted Shares Plan to increase the aggregate number of ordinary shares reserved for issuance by 15,000,000 ordinary shares.                                                                                                                                                                                                                                                                                                                                                                                            | COMPENSATION                                  |           2652 |                0 | FOR         |                                     2652 | FOR                         |  |
| LEGEND BIOTECH CORPORATION       | 52490G102 | 10/21/2024     | To authorize each of the directors and officers of the Company to take any and every action that might be necessary to effect the foregoing resolutions as such director or officer, in his or her absolute discretion, thinks fit.                                                                                                                                                                                                                                                                                                                                                      | CORPORATE GOVERNANCE                          |           2652 |                0 | FOR         |                                     2652 | FOR                         |  |
| LEGEND BIOTECH CORPORATION       | 52490G102 | 06/12/2025     | To receive the audited consolidated financial statements of the Company for the fiscal year ended December 31, 2024.                                                                                                                                                                                                                                                                                                                                                                                                                                                                     | OTHER                                         |           3358 |                0 | FOR         |                                     3358 | FOR                         |  |
| LEGEND BIOTECH CORPORATION       | 52490G102 | 06/12/2025     | To ratify the appointment of Ernst  Young LLP as independent auditor of the Company (the "Independent Auditor") for the fiscal year ending December 31, 2025.                                                                                                                                                                                                                                                                                                                                                                                                                            | AUDIT-RELATED                                 |           3358 |                0 | FOR         |                                     3358 | FOR                         |  |
| LEGEND BIOTECH CORPORATION       | 52490G102 | 06/12/2025     | To re-elect Dr. Patrick Casey, whose term of office will expire pursuant to article 88(b) of the Company's memorandum of association, to serve as a Class II director of the Company for a full term of three (3) years.                                                                                                                                                                                                                                                                                                                                                                 | DIRECTOR ELECTIONS                            |           3358 |                0 | FOR         |                                     3358 | FOR                         |  |
| LEGEND BIOTECH CORPORATION       | 52490G102 | 06/12/2025     | To re-elect Yau Wai Man Philip, whose term of office will expire pursuant to article 88(b) of the Company's memorandum of association, to serve as a Class II director of the Company for a full term of three (3) years.                                                                                                                                                                                                                                                                                                                                                                | DIRECTOR ELECTIONS                            |           3358 |                0 | FOR         |                                     3358 | FOR                         |  |
| LEGEND BIOTECH CORPORATION       | 52490G102 | 06/12/2025     | To re-elect Dr. Fangliang Zhang, whose term of office will expire pursuant to article 88(b) of the Company's memorandum of association, to serve as a Class II director of the Company for a full term of three (3) years.                                                                                                                                                                                                                                                                                                                                                               | DIRECTOR ELECTIONS                            |           3358 |                0 | FOR         |                                     3358 | FOR                         |  |
| LEGEND BIOTECH CORPORATION       | 52490G102 | 06/12/2025     | To authorize each of the directors and officers of the Company to take any and every action that might be necessary to effect the foregoing resolutions as such director or officer, in his or her absolute discretion, thinks fit.                                                                                                                                                                                                                                                                                                                                                      | OTHER                                         |           3358 |                0 | FOR         |                                     3358 | FOR                         |  |
| LYELL IMMUNOPHARMA, INC.         | 55083R104 | 05/15/2025     | Election of Class I Director: Catherine Friedman                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         | DIRECTOR ELECTIONS                            |         246349 |                0 | WITHHOLD    |                                   246349 | AGAINST                     |  |
| LYELL IMMUNOPHARMA, INC.         | 55083R104 | 05/15/2025     | Ratification of the appointment of Ernst  Young LLP as the company's independent registered public accounting firm for its fiscal year ending December 31, 2025.                                                                                                                                                                                                                                                                                                                                                                                                                         | AUDIT-RELATED                                 |         246349 |                0 | FOR         |                                   246349 | FOR                         |  |
| LYELL IMMUNOPHARMA, INC.         | 55083R104 | 05/15/2025     | Approval, on a non-binding advisory basis, of the compensation of the company's named executive officers.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                | SECTION 14A SAY-ON-PAY VOTES                  |         246349 |                0 | FOR         |                                   246349 | FOR                         |  |
| LYELL IMMUNOPHARMA, INC.         | 55083R104 | 05/15/2025     | Approval of a series of alternate amendments to the company's Amended and Restated Certificate of Incorporation to effect a reverse stock split of its common stock at a ratio in the range of 1-for-10 to 1-for-25, with such ratio to be determined in the discretion of the company's board of directors and with such reverse stock split to be effected at such time and date, if at all, as determined by the company's board of directors in its sole discretion.                                                                                                                 | CAPITAL STRUCTURE                             |         246349 |                0 | FOR         |                                   246349 | FOR                         |  |
| MACROGENICS, INC.                | 556099109 | 05/21/2025     | Election of Class III Director to hold office until the 2028 Annual Meeting of Stockholders or until their successors are elected and qualified, or until their earlier death, resignation or removal: Karen Ferrante, M.D.                                                                                                                                                                                                                                                                                                                                                              | DIRECTOR ELECTIONS                            |          45885 |                0 | FOR         |                                    45885 | FOR                         |  |
| MACROGENICS, INC.                | 556099109 | 05/21/2025     | Election of Class III Director to hold office until the 2028 Annual Meeting of Stockholders or until their successors are elected and qualified, or until their earlier death, resignation or removal: William Heiden                                                                                                                                                                                                                                                                                                                                                                    | DIRECTOR ELECTIONS                            |          45885 |                0 | FOR         |                                    45885 | FOR                         |  |
| MACROGENICS, INC.                | 556099109 | 05/21/2025     | Election of Class III Director to hold office until the 2028 Annual Meeting of Stockholders or until their successors are elected and qualified, or until their earlier death, resignation or removal: Edward Hurwitz                                                                                                                                                                                                                                                                                                                                                                    | DIRECTOR ELECTIONS                            |          45885 |                0 | FOR         |                                    45885 | FOR                         |  |
| MACROGENICS, INC.                | 556099109 | 05/21/2025     | Election of Class III Director to hold office until the 2028 Annual Meeting of Stockholders or until their successors are elected and qualified, or until their earlier death, resignation or removal: Meenu Chhabra Karson                                                                                                                                                                                                                                                                                                                                                              | DIRECTOR ELECTIONS                            |          45885 |                0 | FOR         |                                    45885 | FOR                         |  |
| MACROGENICS, INC.                | 556099109 | 05/21/2025     | To ratify the selection by the Audit Committee of the Board of Directors of Ernst  Young LLP as the independent registered public accounting firm of the Company for its fiscal year ending December 31, 2025.                                                                                                                                                                                                                                                                                                                                                                           | AUDIT-RELATED                                 |          45885 |                0 | FOR         |                                    45885 | FOR                         |  |
| MACROGENICS, INC.                | 556099109 | 05/21/2025     | To approve, on an advisory basis, the compensation of the Company's named executive officers as disclosed in the proxy materials.                                                                                                                                                                                                                                                                                                                                                                                                                                                        | SECTION 14A SAY-ON-PAY VOTES                  |          45885 |                0 | FOR         |                                    45885 | FOR                         |  |
| MACROGENICS, INC.                | 556099109 | 05/21/2025     | To approve the amendment to the MacroGenics, Inc. 2023 Equity Incentive Plan, as disclosed in the proxy materials.                                                                                                                                                                                                                                                                                                                                                                                                                                                                       | COMPENSATION                                  |          45885 |                0 | AGAINST     |                                    45885 | AGAINST                     |  |
| MERCK  CO., INC.                 | 58933Y105 | 05/27/2025     | Election of Director: Douglas M. Baker, Jr.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              | DIRECTOR ELECTIONS                            |           1335 |                0 | FOR         |                                     1335 | FOR                         |  |
| MERCK  CO., INC.                 | 58933Y105 | 05/27/2025     | Election of Director: Mary Ellen Coe                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     | DIRECTOR ELECTIONS                            |           1335 |                0 | FOR         |                                     1335 | FOR                         |  |
| MERCK  CO., INC.                 | 58933Y105 | 05/27/2025     | Election of Director: Pamela J. Craig                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    | DIRECTOR ELECTIONS                            |           1335 |                0 | FOR         |                                     1335 | FOR                         |  |
| MERCK  CO., INC.                 | 58933Y105 | 05/27/2025     | Election of Director: Robert M. Davis                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    | DIRECTOR ELECTIONS                            |           1335 |                0 | FOR         |                                     1335 | FOR                         |  |
| MERCK  CO., INC.                 | 58933Y105 | 05/27/2025     | Election of Director: Thomas H. Glocer                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   | DIRECTOR ELECTIONS                            |           1335 |                0 | FOR         |                                     1335 | FOR                         |  |
| MERCK  CO., INC.                 | 58933Y105 | 05/27/2025     | Election of Director: Surendralal L. Karsanbhai                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          | DIRECTOR ELECTIONS                            |           1335 |                0 | FOR         |                                     1335 | FOR                         |  |
| MERCK  CO., INC.                 | 58933Y105 | 05/27/2025     | Election of Director: Risa J. Lavizzo-Mourey, M.D.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       | DIRECTOR ELECTIONS                            |           1335 |                0 | FOR         |                                     1335 | FOR                         |  |
| MERCK  CO., INC.                 | 58933Y105 | 05/27/2025     | Election of Director: Stephen L. Mayo, Ph.D.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             | DIRECTOR ELECTIONS                            |           1335 |                0 | FOR         |                                     1335 | FOR                         |  |
| MERCK  CO., INC.                 | 58933Y105 | 05/27/2025     | Election of Director: Paul B. Rothman, M.D.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              | DIRECTOR ELECTIONS                            |           1335 |                0 | FOR         |                                     1335 | FOR                         |  |
| MERCK  CO., INC.                 | 58933Y105 | 05/27/2025     | Election of Director: Patricia F. Russo                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  | DIRECTOR ELECTIONS                            |           1335 |                0 | FOR         |                                     1335 | FOR                         |  |
| MERCK  CO., INC.                 | 58933Y105 | 05/27/2025     | Election of Director: Christine E. Seidman, M.D.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         | DIRECTOR ELECTIONS                            |           1335 |                0 | FOR         |                                     1335 | FOR                         |  |
| MERCK  CO., INC.                 | 58933Y105 | 05/27/2025     | Election of Director: Inge G. Thulin                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     | DIRECTOR ELECTIONS                            |           1335 |                0 | FOR         |                                     1335 | FOR                         |  |
| MERCK  CO., INC.                 | 58933Y105 | 05/27/2025     | Election of Director: Kathy J. Warden                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    | DIRECTOR ELECTIONS                            |           1335 |                0 | FOR         |                                     1335 | FOR                         |  |
| MERCK  CO., INC.                 | 58933Y105 | 05/27/2025     | Non-binding advisory vote to approve the compensation of our named executive officers.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   | SECTION 14A SAY-ON-PAY VOTES                  |           1335 |                0 | FOR         |                                     1335 | FOR                         |  |
| MERCK  CO., INC.                 | 58933Y105 | 05/27/2025     | Ratification of the appointment of the Company's independent registered public accounting firm for 2025.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 | AUDIT-RELATED                                 |           1335 |                0 | FOR         |                                     1335 | FOR                         |  |
| MERCK  CO., INC.                 | 58933Y105 | 05/27/2025     | Shareholder proposal regarding a human rights impact assessment.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         | HUMAN RIGHTS OR HUMAN CAPITAL/WORKFORCE       |           1335 |                0 | AGAINST     |                                     1335 | FOR                         |  |
| MERCK  CO., INC.                 | 58933Y105 | 05/27/2025     | Shareholder proposal regarding a tax transparency report.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                | OTHER SOCIAL ISSUES                           |           1335 |                0 | AGAINST     |                                     1335 | FOR                         |  |
| MERCK  CO., INC.                 | 58933Y105 | 05/27/2025     | Shareholder proposal to revisit DEI goals in executive pay incentives.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   | OTHER SOCIAL ISSUES                           |           1335 |                0 | AGAINST     |                                     1335 | FOR                         |  |
| MERCK  CO., INC.                 | 58933Y105 | 05/27/2025     | Shareholder proposal regarding a report on civil liberties in advertising services.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      | OTHER SOCIAL ISSUES                           |           1335 |                0 | AGAINST     |                                     1335 | FOR                         |  |
| MERUS N.V.                       | N5749R100 | 05/21/2025     | Adoption of Merus N.V.'s Dutch statutory annual accounts for the financial year 2024.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    | OTHER                                         |           2698 |                0 | FOR         |                                     2698 | FOR                         |  |
| MERUS N.V.                       | N5749R100 | 05/21/2025     | Appointment of KPMG Accountants N.V. as Merus N.V.'s external auditor for the financial year 2025 for purposes of Dutch law.                                                                                                                                                                                                                                                                                                                                                                                                                                                             | AUDIT-RELATED                                 |           2698 |                0 | FOR         |                                     2698 | FOR                         |  |
| MERUS N.V.                       | N5749R100 | 05/21/2025     | Release of each member of Merus N.V.'s board of directors from liability for the exercise of their duties during the financial year 2024.                                                                                                                                                                                                                                                                                                                                                                                                                                                | CORPORATE GOVERNANCE                          |           2698 |                0 | FOR         |                                     2698 | FOR                         |  |
| MERUS N.V.                       | N5749R100 | 05/21/2025     | Opportunity to make recommendations for nomination by Merus N.V.'s group of non-executive directors.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     | CORPORATE GOVERNANCE                          |           2698 |                0 | FOR         |                                     2698 | NONE                        |  |
| MERUS N.V.                       | N5749R100 | 05/21/2025     | Re-appointment of Anand Mehra, M.D. as non-executive director.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           | DIRECTOR ELECTIONS                            |           2698 |                0 | FOR         |                                     2698 | FOR                         |  |
| MERUS N.V.                       | N5749R100 | 05/21/2025     | Opportunity to make recommendations for nomination by Merus N.V.'s group of non-executive directors.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     | CORPORATE GOVERNANCE                          |           2698 |                0 | FOR         |                                     2698 | NONE                        |  |
| MERUS N.V.                       | N5749R100 | 05/21/2025     | Re-appointment of Maxine Gowen, Ph.D. as non-executive director.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         | DIRECTOR ELECTIONS                            |           2698 |                0 | FOR         |                                     2698 | FOR                         |  |
| MERUS N.V.                       | N5749R100 | 05/21/2025     | Granting authorization to Merus N.V.'s board of directors to acquire shares (or depository receipts for such shares) in Merus N.V.'s capital.                                                                                                                                                                                                                                                                                                                                                                                                                                            | CAPITAL STRUCTURE                             |           2698 |                0 | FOR         |                                     2698 | FOR                         |  |
| MERUS N.V.                       | N5749R100 | 05/21/2025     | Approval, on an advisory (non-binding) basis, of the compensation of Merus N.V.'s named executive officers.                                                                                                                                                                                                                                                                                                                                                                                                                                                                              | SECTION 14A SAY-ON-PAY VOTES                  |           2698 |                0 | FOR         |                                     2698 | FOR                         |  |
| MONTE ROSA THERAPEUTICS, INC.    | 61225M102 | 06/13/2025     | Election of Class I Director to serve until the Company's 2028 annual meeting of stockholders and until their successor has been duly elected and qualified, or until their earlier death, resignation or removal: Christine Siu, MBA                                                                                                                                                                                                                                                                                                                                                    | DIRECTOR ELECTIONS                            |          18928 |                0 | FOR         |                                    18928 | FOR                         |  |
| MONTE ROSA THERAPEUTICS, INC.    | 61225M102 | 06/13/2025     | Election of Class I Director to serve until the Company's 2028 annual meeting of stockholders and until their successor has been duly elected and qualified, or until their earlier death, resignation or removal: Kimberly Blackwell, M.D.                                                                                                                                                                                                                                                                                                                                              | DIRECTOR ELECTIONS                            |          18928 |                0 | FOR         |                                    18928 | FOR                         |  |
| MONTE ROSA THERAPEUTICS, INC.    | 61225M102 | 06/13/2025     | Election of Class I Director to serve until the Company's 2028 annual meeting of stockholders and until their successor has been duly elected and qualified, or until their earlier death, resignation or removal: Jan Skvarka, Ph.D., MBA                                                                                                                                                                                                                                                                                                                                               | DIRECTOR ELECTIONS                            |          18928 |                0 | WITHHOLD    |                                    18928 | AGAINST                     |  |
| MONTE ROSA THERAPEUTICS, INC.    | 61225M102 | 06/13/2025     | To ratify the appointment of Deloitte  Touche, LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2025.                                                                                                                                                                                                                                                                                                                                                                                                                                    | AUDIT-RELATED                                 |          18928 |                0 | FOR         |                                    18928 | FOR                         |  |
| NURIX THERAPEUTICS, INC.         | 67080M103 | 05/19/2025     | DIRECTOR: Judith A. Reinsdorf                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            | DIRECTOR ELECTIONS                            |           6187 |                0 | ABSTAIN     |                                     6187 | AGAINST                     |  |
| NURIX THERAPEUTICS, INC.         | 67080M103 | 05/19/2025     | DIRECTOR: Edward C. Saltzman                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             | DIRECTOR ELECTIONS                            |           6187 |                0 | FOR         |                                     6187 | FOR                         |  |
| NURIX THERAPEUTICS, INC.         | 67080M103 | 05/19/2025     | DIRECTOR: Roy D. Baynes                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  | DIRECTOR ELECTIONS                            |           6187 |                0 | FOR         |                                     6187 | FOR                         |  |
| NURIX THERAPEUTICS, INC.         | 67080M103 | 05/19/2025     | Ratification of the appointment of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for the fiscal year ending November 30, 2025.                                                                                                                                                                                                                                                                                                                                                                                                               | AUDIT-RELATED                                 |           6187 |                0 | FOR         |                                     6187 | FOR                         |  |
| NURIX THERAPEUTICS, INC.         | 67080M103 | 05/19/2025     | To approve, on a non-binding advisory basis, the compensation of the Company's named executive officers as disclosed in the Proxy Statement.                                                                                                                                                                                                                                                                                                                                                                                                                                             | SECTION 14A SAY-ON-PAY VOTES                  |           6187 |                0 | FOR         |                                     6187 | FOR                         |  |
| NUVALENT, INC.                   | 670703107 | 06/18/2025     | Election of Class I Director: Grant Bogle                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                | DIRECTOR ELECTIONS                            |           1654 |                0 | FOR         |                                     1654 | FOR                         |  |
| NUVALENT, INC.                   | 670703107 | 06/18/2025     | Election of Class I Director: James R. Porter, Ph.D.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     | DIRECTOR ELECTIONS                            |           1654 |                0 | FOR         |                                     1654 | FOR                         |  |
| NUVALENT, INC.                   | 670703107 | 06/18/2025     | Election of Class I Director: Anna Protopapas                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            | DIRECTOR ELECTIONS                            |           1654 |                0 | WITHHOLD    |                                     1654 | AGAINST                     |  |
| NUVALENT, INC.                   | 670703107 | 06/18/2025     | To approve, on an advisory basis, the compensation paid to our named executive officers.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 | SECTION 14A SAY-ON-PAY VOTES                  |           1654 |                0 | AGAINST     |                                     1654 | AGAINST                     |  |
| NUVALENT, INC.                   | 670703107 | 06/18/2025     | To ratify the appointment of KPMG LLP as Nuvalent, Inc.'s independent registered public accounting firm for the fiscal year ending December 31, 2025.                                                                                                                                                                                                                                                                                                                                                                                                                                    | AUDIT-RELATED                                 |           1654 |                0 | FOR         |                                     1654 | FOR                         |  |
| NUVATION BIO INC.                | 67080N101 | 09/03/2024     | DIRECTOR: Min Cui, Ph.D.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 | DIRECTOR ELECTIONS                            |          89606 |                0 | FOR         |                                    89606 | FOR                         |  |
| NUVATION BIO INC.                | 67080N101 | 09/03/2024     | Ratification of the appointment of KPMG LLP as the independent registered public accounting firm.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        | AUDIT-RELATED                                 |          89606 |                0 | FOR         |                                    89606 | FOR                         |  |
| NUVATION BIO INC.                | 67080N101 | 09/03/2024     | To approve, on an advisory basis, the compensation of the Company's Named Executive Officers as disclosed in the Proxy Statement.                                                                                                                                                                                                                                                                                                                                                                                                                                                        | SECTION 14A SAY-ON-PAY VOTES                  |          89606 |                0 | FOR         |                                    89606 | FOR                         |  |
| NUVATION BIO INC.                | 67080N101 | 09/03/2024     | To approve conversion of the Company's Series A Non-Voting Convertible Preferred Stock to the Company's Class A Common Stock.                                                                                                                                                                                                                                                                                                                                                                                                                                                            | CAPITAL STRUCTURE                             |          89606 |                0 | FOR         |                                    89606 | FOR                         |  |
| NUVATION BIO INC.                | 67080N101 | 09/03/2024     | To approve adjournment of the annual meeting, if necessary or appropriate, to solicit additional proxies.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                | CORPORATE GOVERNANCE                          |          89606 |                0 | FOR         |                                    89606 | FOR                         |  |
| NUVATION BIO INC.                | 67080N101 | 05/21/2025     | DIRECTOR: Kathryn E. Falberg                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             | DIRECTOR ELECTIONS; OTHER                     |          51266 |                0 | ABSTAIN     |                                    51266 | AGAINST                     |  |
| NUVATION BIO INC.                | 67080N101 | 05/21/2025     | Ratification of the appointment of KPMG LLP as the independent registered public accounting firm.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        | AUDIT-RELATED                                 |          51266 |                0 | FOR         |                                    51266 | FOR                         |  |
| NUVATION BIO INC.                | 67080N101 | 05/21/2025     | To approve, on an advisory basis, the compensation of the Company's Named Executive Officers as disclosed in the Proxy Statement.                                                                                                                                                                                                                                                                                                                                                                                                                                                        | SECTION 14A SAY-ON-PAY VOTES                  |          51266 |                0 | FOR         |                                    51266 | FOR                         |  |
| PRECIGEN, INC.                   | 74017N105 | 07/05/2024     | Election of Director: Randal Kirk                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        | DIRECTOR ELECTIONS                            |         165645 |                0 | FOR         |                                   165645 | FOR                         |  |
| PRECIGEN, INC.                   | 74017N105 | 07/05/2024     | Election of Director: Cesar Alvarez                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      | DIRECTOR ELECTIONS                            |         165645 |                0 | FOR         |                                   165645 | FOR                         |  |
| PRECIGEN, INC.                   | 74017N105 | 07/05/2024     | Election of Director: Steven Frank                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       | DIRECTOR ELECTIONS                            |         165645 |                0 | AGAINST     |                                   165645 | AGAINST                     |  |
| PRECIGEN, INC.                   | 74017N105 | 07/05/2024     | Election of Director: Vinita Gupta                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       | DIRECTOR ELECTIONS                            |         165645 |                0 | FOR         |                                   165645 | FOR                         |  |
| PRECIGEN, INC.                   | 74017N105 | 07/05/2024     | Election of Director: Fred Hassan                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        | DIRECTOR ELECTIONS                            |         165645 |                0 | FOR         |                                   165645 | FOR                         |  |
| PRECIGEN, INC.                   | 74017N105 | 07/05/2024     | Election of Director: Jeffrey Kindler                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    | DIRECTOR ELECTIONS                            |         165645 |                0 | FOR         |                                   165645 | FOR                         |  |
| PRECIGEN, INC.                   | 74017N105 | 07/05/2024     | Election of Director: Nancy Howell Agee                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  | DIRECTOR ELECTIONS                            |         165645 |                0 | FOR         |                                   165645 | FOR                         |  |
| PRECIGEN, INC.                   | 74017N105 | 07/05/2024     | Election of Director: Helen Sabzevari                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    | DIRECTOR ELECTIONS                            |         165645 |                0 | FOR         |                                   165645 | FOR                         |  |
| PRECIGEN, INC.                   | 74017N105 | 07/05/2024     | Election of Director: James Turley                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       | DIRECTOR ELECTIONS                            |         165645 |                0 | FOR         |                                   165645 | FOR                         |  |
| PRECIGEN, INC.                   | 74017N105 | 07/05/2024     | Company Proposal - Ratify the appointment of Deloitte  Touche LLP as our independent registered public accounting firm for fiscal year ending December 31, 2024.                                                                                                                                                                                                                                                                                                                                                                                                                         | AUDIT-RELATED                                 |         165645 |                0 | FOR         |                                   165645 | FOR                         |  |
| PRECIGEN, INC.                   | 74017N105 | 07/05/2024     | Company Proposal - Advisory vote to approve executive compensation.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      | SECTION 14A SAY-ON-PAY VOTES                  |         165645 |                0 | FOR         |                                   165645 | FOR                         |  |
| PRECIGEN, INC.                   | 74017N105 | 07/05/2024     | Company Proposal - Approval of an Amendment to the Precigen, Inc. 2023 Omnibus Incentive Plan.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           | COMPENSATION                                  |         165645 |                0 | FOR         |                                   165645 | FOR                         |  |
| PRECIGEN, INC.                   | 74017N105 | 06/26/2025     | Election of Director: Randal Kirk                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        | DIRECTOR ELECTIONS                            |          71566 |                0 | FOR         |                                    71566 | FOR                         |  |
| PRECIGEN, INC.                   | 74017N105 | 06/26/2025     | Election of Director: Cesar Alvarez                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      | DIRECTOR ELECTIONS                            |          71566 |                0 | AGAINST     |                                    71566 | AGAINST                     |  |
| PRECIGEN, INC.                   | 74017N105 | 06/26/2025     | Election of Director: Steven Frank                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       | DIRECTOR ELECTIONS                            |          71566 |                0 | FOR         |                                    71566 | FOR                         |  |
| PRECIGEN, INC.                   | 74017N105 | 06/26/2025     | Election of Director: Vinita Gupta                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       | DIRECTOR ELECTIONS                            |          71566 |                0 | FOR         |                                    71566 | FOR                         |  |
| PRECIGEN, INC.                   | 74017N105 | 06/26/2025     | Election of Director: Fred Hassan                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        | DIRECTOR ELECTIONS                            |          71566 |                0 | FOR         |                                    71566 | FOR                         |  |
| PRECIGEN, INC.                   | 74017N105 | 06/26/2025     | Election of Director: Jeffrey Kindler                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    | DIRECTOR ELECTIONS                            |          71566 |                0 | FOR         |                                    71566 | FOR                         |  |
| PRECIGEN, INC.                   | 74017N105 | 06/26/2025     | Election of Director: Nancy Howell Agee                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  | DIRECTOR ELECTIONS                            |          71566 |                0 | FOR         |                                    71566 | FOR                         |  |
| PRECIGEN, INC.                   | 74017N105 | 06/26/2025     | Election of Director: Helen Sabzevari                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    | DIRECTOR ELECTIONS                            |          71566 |                0 | FOR         |                                    71566 | FOR                         |  |
| PRECIGEN, INC.                   | 74017N105 | 06/26/2025     | Election of Director: James Turley                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       | DIRECTOR ELECTIONS                            |          71566 |                0 | FOR         |                                    71566 | FOR                         |  |
| PRECIGEN, INC.                   | 74017N105 | 06/26/2025     | Company Proposal - Approval of an amendment to the Company's Amended and Restated Articles of Incorporation to increase the Company's authorized shares of common stock.                                                                                                                                                                                                                                                                                                                                                                                                                 | CAPITAL STRUCTURE                             |          71566 |                0 | FOR         |                                    71566 | FOR                         |  |
| PRECIGEN, INC.                   | 74017N105 | 06/26/2025     | Company Proposal - Approval, in compliance with Nasdaq Listing Rule 5635(c), of the additional issuance of shares of Series A Preferred Stock and Warrants to Randal J. Kirk as PIK dividends, in order for Mr. Kirk to receive PIK dividends on the Series A Preferred Stock on the same terms as the other investors.                                                                                                                                                                                                                                                                  | COMPENSATION                                  |          71566 |                0 | AGAINST     |                                    71566 | AGAINST                     |  |
| PRECIGEN, INC.                   | 74017N105 | 06/26/2025     | Company Proposal - Ratify the appointment of Deloitte  Touche LLP as our independent registered public accounting firm for fiscal year ending December 31, 2025.                                                                                                                                                                                                                                                                                                                                                                                                                         | AUDIT-RELATED                                 |          71566 |                0 | FOR         |                                    71566 | FOR                         |  |
| PRECIGEN, INC.                   | 74017N105 | 06/26/2025     | Company Proposal - Advisory vote to approve executive compensation.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      | SECTION 14A SAY-ON-PAY VOTES                  |          71566 |                0 | FOR         |                                    71566 | FOR                         |  |
| PRECIGEN, INC.                   | 74017N105 | 06/26/2025     | Company Proposal - Approval of an amendment to the 2023 Omnibus Incentive Plan.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          | COMPENSATION                                  |          71566 |                0 | FOR         |                                    71566 | FOR                         |  |
| PRECIGEN, INC.                   | 74017N105 | 06/26/2025     | Company Proposal - Approval of an amendment to the 2019 Incentive Plan for Non-Employee Service Providers.                                                                                                                                                                                                                                                                                                                                                                                                                                                                               | COMPENSATION                                  |          71566 |                0 | FOR         |                                    71566 | FOR                         |  |
| RAPT THERAPEUTICS, INC.          | 75382E109 | 05/29/2025     | Election of Class III Director to hold office until RAPT Therapeutics, Inc.'s 2028 annual meeting of stockholders or until his successor has been duly elected and qualified: Dr. Michael F. Giordano                                                                                                                                                                                                                                                                                                                                                                                    | DIRECTOR ELECTIONS                            |         113738 |                0 | WITHHOLD    |                                   113738 | AGAINST                     |  |
| RAPT THERAPEUTICS, INC.          | 75382E109 | 05/29/2025     | Ratification of the appointment of Ernst  Young LLP as the independent registered public accounting firm of RAPT Therapeutics, Inc. for its fiscal year ending December 31, 2025.                                                                                                                                                                                                                                                                                                                                                                                                        | AUDIT-RELATED                                 |         113738 |                0 | FOR         |                                   113738 | FOR                         |  |
| RAPT THERAPEUTICS, INC.          | 75382E109 | 05/29/2025     | To approve, on an advisory basis, the compensation of RAPT Therapeutics, Inc.'s named executive officers.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                | SECTION 14A SAY-ON-PAY VOTES                  |         113738 |                0 | AGAINST     |                                   113738 | AGAINST                     |  |
| RAPT THERAPEUTICS, INC.          | 75382E109 | 05/29/2025     | To indicate, on an advisory basis, the preferred frequency of stockholder advisory votes on the compensation of RAPT Therapeutics, Inc.'s named executive officers.                                                                                                                                                                                                                                                                                                                                                                                                                      | SECTION 14A SAY-ON-PAY VOTES                  |         113738 |                0 | 1 YEAR      |                                   113738 | FOR                         |  |
| RAPT THERAPEUTICS, INC.          | 75382E109 | 05/29/2025     | To approve the amendment of RAPT Therapeutics, Inc.'s Amended and Restated Certificate of Incorporation to effect, at the discretion of the Board of Directors, a reverse stock split of RAPT Therapeutics Inc.'s issued and outstanding common stock, at a ratio of one-for-eight.                                                                                                                                                                                                                                                                                                      | CAPITAL STRUCTURE                             |         113738 |                0 | FOR         |                                   113738 | FOR                         |  |
| RAPT THERAPEUTICS, INC.          | 75382E109 | 05/29/2025     | To approve RAPT Therapeutics, Inc.'s 2025 Equity Incentive Plan.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         | COMPENSATION                                  |         113738 |                0 | AGAINST     |                                   113738 | AGAINST                     |  |
| RAPT THERAPEUTICS, INC.          | 75382E109 | 05/29/2025     | To approve the amendment and restatement of RAPT Therapeutics, Inc.'s 2019 Employee Stock Purchase Plan to remove the evergreen provision and increase the aggregate number of shares of the RAPT Therapeutics, Inc.'s common stock reserved for issuance under the ESPP by 4,000,000 shares.                                                                                                                                                                                                                                                                                            | CAPITAL STRUCTURE                             |         113738 |                0 | FOR         |                                   113738 | FOR                         |  |
| RECURSION PHARMACEUTICALS, INC.  | 75629V104 | 11/12/2024     | To approve the issuance of shares of Class A Common Stock of Recursion Pharmaceuticals, Inc. ("Recursion") in connection with Recursion's acquisition of the entire issued and to be issued share capital of Exscientia plc pursuant to a scheme of arrangement under Part 26 of the United Kingdom Companies Act 2006, for purposes of complying with the applicable provisions of the Nasdaq Listing Rules (the "Recursion Share Issuance Proposal").                                                                                                                                  | EXTRAORDINARY TRANSACTIONS; CAPITAL STRUCTURE |          25182 |                0 | FOR         |                                    25182 | FOR                         |  |
| RECURSION PHARMACEUTICALS, INC.  | 75629V104 | 11/12/2024     | To approve any motion to adjourn the special meeting of stockholders of Recursion (the "Recursion Special Meeting") to another time or place, if necessary or appropriate, including to solicit additional proxies if there are insufficient votes at the time of the Recursion Special Meeting to approve the Recursion Share Issuance Proposal.                                                                                                                                                                                                                                        | CORPORATE GOVERNANCE                          |          25182 |                0 | FOR         |                                    25182 | FOR                         |  |
| RECURSION PHARMACEUTICALS, INC.  | 75629V104 | 06/18/2025     | DIRECTOR: Zachary Bogue, J.D.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            | DIRECTOR ELECTIONS                            |          18624 |                0 | FOR         |                                    18624 | FOR                         |  |
| RECURSION PHARMACEUTICALS, INC.  | 75629V104 | 06/18/2025     | DIRECTOR: Zavain Dar                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     | DIRECTOR ELECTIONS                            |          18624 |                0 | ABSTAIN     |                                    18624 | AGAINST                     |  |
| RECURSION PHARMACEUTICALS, INC.  | 75629V104 | 06/18/2025     | DIRECTOR: Robert Hershberg MD PhD                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        | DIRECTOR ELECTIONS                            |          18624 |                0 | FOR         |                                    18624 | FOR                         |  |
| RECURSION PHARMACEUTICALS, INC.  | 75629V104 | 06/18/2025     | Advisory vote to approve executive compensation as disclosed in the 2025 Proxy Statement.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                | SECTION 14A SAY-ON-PAY VOTES                  |          18624 |                0 | FOR         |                                    18624 | FOR                         |  |
| RECURSION PHARMACEUTICALS, INC.  | 75629V104 | 06/18/2025     | Ratification of the appointment of PricewaterhouseCoopers LLP as our independent registered public accounting firm for fiscal year ending December 31, 2025.                                                                                                                                                                                                                                                                                                                                                                                                                             | AUDIT-RELATED                                 |          18624 |                0 | FOR         |                                    18624 | FOR                         |  |
| REGENERON PHARMACEUTICALS, INC.  | 75886F107 | 06/13/2025     | Election of Director: Bonnie L. Bassler, Ph.D.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           | DIRECTOR ELECTIONS                            |            188 |                0 | AGAINST     |                                      188 | AGAINST                     |  |
| REGENERON PHARMACEUTICALS, INC.  | 75886F107 | 06/13/2025     | Election of Director: Michael S. Brown, M.D.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             | DIRECTOR ELECTIONS                            |            188 |                0 | AGAINST     |                                      188 | AGAINST                     |  |
| REGENERON PHARMACEUTICALS, INC.  | 75886F107 | 06/13/2025     | Election of Director: Leonard S. Schleifer, M.D., Ph.D.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  | DIRECTOR ELECTIONS                            |            188 |                0 | FOR         |                                      188 | FOR                         |  |
| REGENERON PHARMACEUTICALS, INC.  | 75886F107 | 06/13/2025     | Election of Director: George D. Yancopoulos, M.D., Ph.D.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 | DIRECTOR ELECTIONS                            |            188 |                0 | FOR         |                                      188 | FOR                         |  |
| REGENERON PHARMACEUTICALS, INC.  | 75886F107 | 06/13/2025     | Ratification of the appointment of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2025.                                                                                                                                                                                                                                                                                                                                                                                                               | AUDIT-RELATED                                 |            188 |                0 | FOR         |                                      188 | FOR                         |  |
| REGENERON PHARMACEUTICALS, INC.  | 75886F107 | 06/13/2025     | Proposal to approve, on an advisory basis, executive compensation.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       | SECTION 14A SAY-ON-PAY VOTES                  |            188 |                0 | FOR         |                                      188 | FOR                         |  |
| REGENERON PHARMACEUTICALS, INC.  | 75886F107 | 06/13/2025     | Proposal to approve an amendment to the Company's Certificate of Incorporation to declassify the board of directors.                                                                                                                                                                                                                                                                                                                                                                                                                                                                     | SHAREHOLDER RIGHTS AND DEFENSES               |            188 |                0 | FOR         |                                      188 | FOR                         |  |
| REGENERON PHARMACEUTICALS, INC.  | 75886F107 | 06/13/2025     | Proposal to approve an amendment to Article IV, Section 2(e)(8) of the Certificate of Incorporation.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     | CORPORATE GOVERNANCE                          |            188 |                0 | FOR         |                                      188 | FOR                         |  |
| REGENERON PHARMACEUTICALS, INC.  | 75886F107 | 06/13/2025     | Proposal to approve an amendment to Article VI of the Certificate of Incorporation.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      | CORPORATE GOVERNANCE                          |            188 |                0 | FOR         |                                      188 | FOR                         |  |
| RELAY THERAPEUTICS, INC.         | 75943R102 | 06/06/2025     | Election of Class II Director to serve until the 2028 Annual Meeting of stockholders and until their successor has been duly elected and qualified, or until such director's earlier death, resignation or removal: Alexis Borisy                                                                                                                                                                                                                                                                                                                                                        | DIRECTOR ELECTIONS                            |          36293 |                0 | WITHHOLD    |                                    36293 | AGAINST                     |  |
| RELAY THERAPEUTICS, INC.         | 75943R102 | 06/06/2025     | Election of Class II Director to serve until the 2028 Annual Meeting of stockholders and until their successor has been duly elected and qualified, or until such director's earlier death, resignation or removal: Mark Murcko, Ph.D.                                                                                                                                                                                                                                                                                                                                                   | DIRECTOR ELECTIONS                            |          36293 |                0 | WITHHOLD    |                                    36293 | AGAINST                     |  |
| RELAY THERAPEUTICS, INC.         | 75943R102 | 06/06/2025     | To consider and act upon an advisory vote on the compensation of our named executive officers.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           | SECTION 14A SAY-ON-PAY VOTES                  |          36293 |                0 | AGAINST     |                                    36293 | AGAINST                     |  |
| RELAY THERAPEUTICS, INC.         | 75943R102 | 06/06/2025     | To ratify the appointment of Ernst  Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2025.                                                                                                                                                                                                                                                                                                                                                                                                                                         | AUDIT-RELATED                                 |          36293 |                0 | FOR         |                                    36293 | FOR                         |  |
| REPLIMUNE GROUP INC              | 76029N106 | 09/04/2024     | Election of Director: Sushil Patel                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       | DIRECTOR ELECTIONS                            |          23392 |                0 | FOR         |                                    23392 | FOR                         |  |
| REPLIMUNE GROUP INC              | 76029N106 | 09/04/2024     | Election of Director: Dieter Weinand                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     | DIRECTOR ELECTIONS                            |          23392 |                0 | WITHHOLD    |                                    23392 | AGAINST                     |  |
| REPLIMUNE GROUP INC              | 76029N106 | 09/04/2024     | Election of Director: Madhavan Balachandran                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              | DIRECTOR ELECTIONS                            |          23392 |                0 | FOR         |                                    23392 | FOR                         |  |
| REPLIMUNE GROUP INC              | 76029N106 | 09/04/2024     | To ratify the selection of PricewaterhouseCoopers LLP as the independent registered public accounting firm for Replimune Group, Inc. for the fiscal year ending March 31, 2025.                                                                                                                                                                                                                                                                                                                                                                                                          | AUDIT-RELATED                                 |          23392 |                0 | FOR         |                                    23392 | FOR                         |  |
| REPLIMUNE GROUP INC              | 76029N106 | 09/04/2024     | To approve, on a non-binding advisory basis, the compensation of Replimune Group, Inc.'s named executive officers.                                                                                                                                                                                                                                                                                                                                                                                                                                                                       | SECTION 14A SAY-ON-PAY VOTES                  |          23392 |                0 | FOR         |                                    23392 | FOR                         |  |
| REPLIMUNE GROUP INC              | 76029N106 | 09/04/2024     | To approve, on a non-binding advisory basis, the preferred frequency of future advisory votes on the compensation of Replimune Group, Inc.'s named executive officers.                                                                                                                                                                                                                                                                                                                                                                                                                   | SECTION 14A SAY-ON-PAY VOTES                  |          23392 |                0 | 1 YEAR      |                                    23392 | FOR                         |  |
| REVOLUTION MEDICINES, INC.       | 76155X100 | 06/26/2025     | DIRECTOR: Frank K. Clyburn, Jr.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          | DIRECTOR ELECTIONS                            |           3255 |                0 | FOR         |                                     3255 | FOR                         |  |
| REVOLUTION MEDICINES, INC.       | 76155X100 | 06/26/2025     | DIRECTOR: Sandra J. Horning, M.D.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        | DIRECTOR ELECTIONS                            |           3255 |                0 | ABSTAIN     |                                     3255 | AGAINST                     |  |
| REVOLUTION MEDICINES, INC.       | 76155X100 | 06/26/2025     | DIRECTOR: Sushil Patel, Ph.D.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            | DIRECTOR ELECTIONS                            |           3255 |                0 | ABSTAIN     |                                     3255 | AGAINST                     |  |
| REVOLUTION MEDICINES, INC.       | 76155X100 | 06/26/2025     | DIRECTOR: Thilo Schroeder, Ph.D.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         | DIRECTOR ELECTIONS                            |           3255 |                0 | ABSTAIN     |                                     3255 | AGAINST                     |  |
| REVOLUTION MEDICINES, INC.       | 76155X100 | 06/26/2025     | To ratify the appointment, by the Audit Committee of the Company's Board of Directors, of PricewaterhouseCoopers LLP, as the independent registered public accounting firm of the Company for its fiscal year ending December 31, 2025.                                                                                                                                                                                                                                                                                                                                                  | AUDIT-RELATED                                 |           3255 |                0 | FOR         |                                     3255 | FOR                         |  |
| REVOLUTION MEDICINES, INC.       | 76155X100 | 06/26/2025     | To approve, on a non-binding, advisory basis, the compensation of the Company's named executive officers as disclosed in the Proxy Statement pursuant to the compensation disclosure rules of the Securities and Exchange Commission ("Say-on-Pay").                                                                                                                                                                                                                                                                                                                                     | SECTION 14A SAY-ON-PAY VOTES                  |           3255 |                0 | FOR         |                                     3255 | FOR                         |  |
| SCHRODINGER, INC.                | 80810D103 | 06/18/2025     | Election of Class II Director to serve until the 2028 Annual Meeting of Stockholders: Jeffrey Chodakewitz                                                                                                                                                                                                                                                                                                                                                                                                                                                                                | DIRECTOR ELECTIONS                            |           5368 |                0 | FOR         |                                     5368 | FOR                         |  |
| SCHRODINGER, INC.                | 80810D103 | 06/18/2025     | Election of Class II Director to serve until the 2028 Annual Meeting of Stockholders: Michael Lynton                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     | DIRECTOR ELECTIONS                            |           5368 |                0 | AGAINST     |                                     5368 | AGAINST                     |  |
| SCHRODINGER, INC.                | 80810D103 | 06/18/2025     | Election of Class II Director to serve until the 2028 Annual Meeting of Stockholders: Nancy A. Thornberry                                                                                                                                                                                                                                                                                                                                                                                                                                                                                | DIRECTOR ELECTIONS                            |           5368 |                0 | FOR         |                                     5368 | FOR                         |  |
| SCHRODINGER, INC.                | 80810D103 | 06/18/2025     | Election of Class II Director to serve until the 2028 Annual Meeting of Stockholders: Bridget van Kralingen                                                                                                                                                                                                                                                                                                                                                                                                                                                                              | DIRECTOR ELECTIONS                            |           5368 |                0 | FOR         |                                     5368 | FOR                         |  |
| SCHRODINGER, INC.                | 80810D103 | 06/18/2025     | Approval of an advisory vote on executive compensation.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  | SECTION 14A SAY-ON-PAY VOTES                  |           5368 |                0 | FOR         |                                     5368 | FOR                         |  |
| SCHRODINGER, INC.                | 80810D103 | 06/18/2025     | Ratification of the appointment of KPMG LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2025.                                                                                                                                                                                                                                                                                                                                                                                                                                           | AUDIT-RELATED                                 |           5368 |                0 | FOR         |                                     5368 | FOR                         |  |
| SPRINGWORKS THERAPEUTICS INC     | 85205L107 | 05/14/2025     | Election of Class III Director: Alan Fuhrman                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             | DIRECTOR ELECTIONS                            |           4426 |                0 | WITHHOLD    |                                     4426 | AGAINST                     |  |
| SPRINGWORKS THERAPEUTICS INC     | 85205L107 | 05/14/2025     | Election of Class III Director: Julie Hambleton, M.D.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    | DIRECTOR ELECTIONS                            |           4426 |                0 | FOR         |                                     4426 | FOR                         |  |
| SPRINGWORKS THERAPEUTICS INC     | 85205L107 | 05/14/2025     | Election of Class III Director: Daniel S. Lynch, M.B.A.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  | DIRECTOR ELECTIONS                            |           4426 |                0 | FOR         |                                     4426 | FOR                         |  |
| SPRINGWORKS THERAPEUTICS INC     | 85205L107 | 05/14/2025     | Ratification of the appointment of Ernst  Young LLP as SpringWorks Therapeutics' independent registered public accounting firm for the fiscal year ending December 31, 2025                                                                                                                                                                                                                                                                                                                                                                                                              | AUDIT-RELATED                                 |           4426 |                0 | FOR         |                                     4426 | FOR                         |  |
| SPRINGWORKS THERAPEUTICS INC     | 85205L107 | 05/14/2025     | Non-binding advisory vote on executive compensation                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      | SECTION 14A SAY-ON-PAY VOTES                  |           4426 |                0 | FOR         |                                     4426 | FOR                         |  |
| SUMMIT THERAPEUTICS INC.         | 86627T108 | 06/12/2025     | Election of Director: Robert W. Duggan                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   | DIRECTOR ELECTIONS                            |           6328 |                0 | AGAINST     |                                     6328 | AGAINST                     |  |
| SUMMIT THERAPEUTICS INC.         | 86627T108 | 06/12/2025     | Election of Director: Mahkam Zanganeh                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    | DIRECTOR ELECTIONS                            |           6328 |                0 | AGAINST     |                                     6328 | AGAINST                     |  |
| SUMMIT THERAPEUTICS INC.         | 86627T108 | 06/12/2025     | Election of Director: Manmeet S. Soni                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    | DIRECTOR ELECTIONS                            |           6328 |                0 | AGAINST     |                                     6328 | AGAINST                     |  |
| SUMMIT THERAPEUTICS INC.         | 86627T108 | 06/12/2025     | Election of Director: Kenneth A. Clark                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   | DIRECTOR ELECTIONS                            |           6328 |                0 | AGAINST     |                                     6328 | AGAINST                     |  |
| SUMMIT THERAPEUTICS INC.         | 86627T108 | 06/12/2025     | Election of Director: Robert Booth                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       | DIRECTOR ELECTIONS                            |           6328 |                0 | FOR         |                                     6328 | FOR                         |  |
| SUMMIT THERAPEUTICS INC.         | 86627T108 | 06/12/2025     | Election of Director: Alessandra Cesano                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  | DIRECTOR ELECTIONS                            |           6328 |                0 | FOR         |                                     6328 | FOR                         |  |
| SUMMIT THERAPEUTICS INC.         | 86627T108 | 06/12/2025     | Election of Director: Yu (Michelle) Xia                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  | DIRECTOR ELECTIONS                            |           6328 |                0 | AGAINST     |                                     6328 | AGAINST                     |  |
| SUMMIT THERAPEUTICS INC.         | 86627T108 | 06/12/2025     | Election of Director: Mostafa Ronaghi                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    | DIRECTOR ELECTIONS                            |           6328 |                0 | FOR         |                                     6328 | FOR                         |  |
| SUMMIT THERAPEUTICS INC.         | 86627T108 | 06/12/2025     | Election of Director: Jeff Huber                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         | DIRECTOR ELECTIONS                            |           6328 |                0 | FOR         |                                     6328 | FOR                         |  |
| SUMMIT THERAPEUTICS INC.         | 86627T108 | 06/12/2025     | Ratification of the appointment of PricewaterhouseCoopers LLP as Independent Registered Public Accounting Firm for the fiscal year ending December 31, 2025.                                                                                                                                                                                                                                                                                                                                                                                                                             | AUDIT-RELATED                                 |           6328 |                0 | FOR         |                                     6328 | FOR                         |  |
| SUMMIT THERAPEUTICS INC.         | 86627T108 | 06/12/2025     | Approval, by a non-binding advisory vote, of the compensation of our named executive officers.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           | SECTION 14A SAY-ON-PAY VOTES                  |           6328 |                0 | AGAINST     |                                     6328 | AGAINST                     |  |
| SUTRO BIOPHARMA, INC.            | 869367102 | 06/06/2025     | DIRECTOR: Heidi Hunter                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   | DIRECTOR ELECTIONS                            |         136623 |                0 | ABSTAIN     |                                   136623 | AGAINST                     |  |
| SUTRO BIOPHARMA, INC.            | 869367102 | 06/06/2025     | DIRECTOR: Jon Wigginton, M.D.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            | DIRECTOR ELECTIONS                            |         136623 |                0 | ABSTAIN     |                                   136623 | AGAINST                     |  |
| SUTRO BIOPHARMA, INC.            | 869367102 | 06/06/2025     | DIRECTOR: Michael Dybbs, Ph.D.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           | DIRECTOR ELECTIONS                            |         136623 |                0 | ABSTAIN     |                                   136623 | AGAINST                     |  |
| SUTRO BIOPHARMA, INC.            | 869367102 | 06/06/2025     | To ratify the appointment of Ernst  Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2025.                                                                                                                                                                                                                                                                                                                                                                                                                                         | AUDIT-RELATED                                 |         136623 |                0 | FOR         |                                   136623 | FOR                         |  |
| SUTRO BIOPHARMA, INC.            | 869367102 | 06/06/2025     | To approve, on a non-binding, advisory basis, the compensation of our named executive officers.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          | SECTION 14A SAY-ON-PAY VOTES                  |         136623 |                0 | FOR         |                                   136623 | FOR                         |  |
| SUTRO BIOPHARMA, INC.            | 869367102 | 06/06/2025     | To approve an amendment to our Restated Certificate of Incorporation to effect a reverse stock split of our outstanding shares of common stock at a ratio of any whole number between 1- for-5 and 1-for-25, with the exact ratio determined by the board of directors in its discretion, subject to the board of directors' authority to abandon such amendment.                                                                                                                                                                                                                        | CAPITAL STRUCTURE                             |         136623 |                0 | FOR         |                                   136623 | FOR                         |  |
| SYNDAX PHARMACEUTICALS, INC      | 87164F105 | 05/14/2025     | Election of Director: Keith A. Katkin                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    | DIRECTOR ELECTIONS                            |           8648 |                0 | WITHHOLD    |                                     8648 | AGAINST                     |  |
| SYNDAX PHARMACEUTICALS, INC      | 87164F105 | 05/14/2025     | Election of Director: Dennis G. Podlesak                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 | DIRECTOR ELECTIONS                            |           8648 |                0 | WITHHOLD    |                                     8648 | AGAINST                     |  |
| SYNDAX PHARMACEUTICALS, INC      | 87164F105 | 05/14/2025     | Election of Director: Aleksandra Rizo, M.D., Ph.D.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       | DIRECTOR ELECTIONS                            |           8648 |                0 | FOR         |                                     8648 | FOR                         |  |
| SYNDAX PHARMACEUTICALS, INC      | 87164F105 | 05/14/2025     | To approve, on an advisory basis, the compensation of the Company's named executive officers, as disclosed in the 2025 proxy statement.                                                                                                                                                                                                                                                                                                                                                                                                                                                  | SECTION 14A SAY-ON-PAY VOTES                  |           8648 |                0 | FOR         |                                     8648 | FOR                         |  |
| SYNDAX PHARMACEUTICALS, INC      | 87164F105 | 05/14/2025     | To ratify the selection of Deloitte  Touche LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2025.                                                                                                                                                                                                                                                                                                                                                                                                                             | AUDIT-RELATED                                 |           8648 |                0 | FOR         |                                     8648 | FOR                         |  |
| TANGO THERAPEUTICS, INC.         | 87583X109 | 06/05/2025     | Election of Class I Director: Lesley Ann Calhoun                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         | DIRECTOR ELECTIONS                            |          65327 |                0 | WITHHOLD    |                                    65327 | AGAINST                     |  |
| TANGO THERAPEUTICS, INC.         | 87583X109 | 06/05/2025     | To ratify the selection of PricewaterhouseCoopers LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2025.                                                                                                                                                                                                                                                                                                                                                                                                                                 | AUDIT-RELATED                                 |          65327 |                0 | FOR         |                                    65327 | FOR                         |  |
| TANGO THERAPEUTICS, INC.         | 87583X109 | 06/05/2025     | To approve an amendment to our Second Amended and Restated Certificate of Incorporation to increase the number of authorized shares of common stock from 200,000,000 to 400,000,000.                                                                                                                                                                                                                                                                                                                                                                                                     | CAPITAL STRUCTURE                             |          65327 |                0 | FOR         |                                    65327 | FOR                         |  |
| TANGO THERAPEUTICS, INC.         | 87583X109 | 06/05/2025     | To approve, on a non-binding, advisory basis, the compensation of our named executive officers.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          | SECTION 14A SAY-ON-PAY VOTES                  |          65327 |                0 | FOR         |                                    65327 | FOR                         |  |
| TANGO THERAPEUTICS, INC.         | 87583X109 | 06/05/2025     | Non-binding, advisory vote on the frequency of future non-binding, advisory votes on the compensation of our named executive officers.                                                                                                                                                                                                                                                                                                                                                                                                                                                   | SECTION 14A SAY-ON-PAY VOTES                  |          65327 |                0 | 1 YEAR      |                                    65327 | FOR                         |  |
| TYRA BIOSCIENCES, INC.           | 90240B106 | 05/29/2025     | Election of Class I Director to serve for a three-year term expiring at the 2028 Annual Meeting of Stockholders and until their respective successors shall have been duly elected and qualified: Todd Harris, Ph.D.                                                                                                                                                                                                                                                                                                                                                                     | DIRECTOR ELECTIONS                            |          11861 |                0 | WITHHOLD    |                                    11861 | AGAINST                     |  |
| TYRA BIOSCIENCES, INC.           | 90240B106 | 05/29/2025     | Election of Class I Director to serve for a three-year term expiring at the 2028 Annual Meeting of Stockholders and until their respective successors shall have been duly elected and qualified: Adele M. Gulfo                                                                                                                                                                                                                                                                                                                                                                         | DIRECTOR ELECTIONS                            |          11861 |                0 | FOR         |                                    11861 | FOR                         |  |
| TYRA BIOSCIENCES, INC.           | 90240B106 | 05/29/2025     | Election of Class I Director to serve for a three-year term expiring at the 2028 Annual Meeting of Stockholders and until their respective successors shall have been duly elected and qualified: S. Michael Rothenberg, M.D., Ph.D.                                                                                                                                                                                                                                                                                                                                                     | DIRECTOR ELECTIONS                            |          11861 |                0 | WITHHOLD    |                                    11861 | AGAINST                     |  |
| TYRA BIOSCIENCES, INC.           | 90240B106 | 05/29/2025     | To ratify the appointment of Ernst  Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2025.                                                                                                                                                                                                                                                                                                                                                                                                                                         | AUDIT-RELATED                                 |          11861 |                0 | FOR         |                                    11861 | FOR                         |  |
| VOR BIOPHARMA INC.               | 929033108 | 05/22/2025     | DIRECTOR: Matthew Patterson                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              | DIRECTOR ELECTIONS; OTHER                     |         155827 |                0 | ABSTAIN     |                                   155827 | AGAINST                     |  |
| VOR BIOPHARMA INC.               | 929033108 | 05/22/2025     | DIRECTOR: Daniella Beckman                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               | DIRECTOR ELECTIONS; OTHER                     |         155827 |                0 | ABSTAIN     |                                   155827 | AGAINST                     |  |
| VOR BIOPHARMA INC.               | 929033108 | 05/22/2025     | To approve an amendment to the Company's Amended and Restated Certificate of Incorporation, as amended to date, to increase the number of authorized shares of common stock from 400,000,000 to 800,000,000.                                                                                                                                                                                                                                                                                                                                                                             | CAPITAL STRUCTURE                             |         155827 |                0 | FOR         |                                   155827 | FOR                         |  |
| VOR BIOPHARMA INC.               | 929033108 | 05/22/2025     | To ratify the selection by the audit committee of the Board of Directors of Ernst  Young LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2025.                                                                                                                                                                                                                                                                                                                                                                                          | AUDIT-RELATED                                 |         155827 |                0 | FOR         |                                   155827 | FOR                         |  |
| XENCOR, INC.                     | 98401F105 | 06/12/2025     | Election of Director to serve until the next Annual Meeting and until their successors are duly elected and qualified: Dr. Bassil I. Dahiyat                                                                                                                                                                                                                                                                                                                                                                                                                                             | DIRECTOR ELECTIONS                            |           9814 |                0 | FOR         |                                     9814 | FOR                         |  |
| XENCOR, INC.                     | 98401F105 | 06/12/2025     | Election of Director to serve until the next Annual Meeting and until their successors are duly elected and qualified: Dr. Ellen G. Feigal                                                                                                                                                                                                                                                                                                                                                                                                                                               | DIRECTOR ELECTIONS                            |           9814 |                0 | FOR         |                                     9814 | FOR                         |  |
| XENCOR, INC.                     | 98401F105 | 06/12/2025     | Election of Director to serve until the next Annual Meeting and until their successors are duly elected and qualified: Dr. Kevin C. Gorman                                                                                                                                                                                                                                                                                                                                                                                                                                               | DIRECTOR ELECTIONS                            |           9814 |                0 | FOR         |                                     9814 | FOR                         |  |
| XENCOR, INC.                     | 98401F105 | 06/12/2025     | Election of Director to serve until the next Annual Meeting and until their successors are duly elected and qualified: Mr. Kurt A. Gustafson                                                                                                                                                                                                                                                                                                                                                                                                                                             | DIRECTOR ELECTIONS                            |           9814 |                0 | FOR         |                                     9814 | FOR                         |  |
| XENCOR, INC.                     | 98401F105 | 06/12/2025     | Election of Director to serve until the next Annual Meeting and until their successors are duly elected and qualified: Dr. Barbara Klencke                                                                                                                                                                                                                                                                                                                                                                                                                                               | DIRECTOR ELECTIONS                            |           9814 |                0 | FOR         |                                     9814 | FOR                         |  |
| XENCOR, INC.                     | 98401F105 | 06/12/2025     | Election of Director to serve until the next Annual Meeting and until their successors are duly elected and qualified: Dr. A. Bruce Montgomery                                                                                                                                                                                                                                                                                                                                                                                                                                           | DIRECTOR ELECTIONS                            |           9814 |                0 | FOR         |                                     9814 | FOR                         |  |
| XENCOR, INC.                     | 98401F105 | 06/12/2025     | Election of Director to serve until the next Annual Meeting and until their successors are duly elected and qualified: Mr. Richard J. Ranieri                                                                                                                                                                                                                                                                                                                                                                                                                                            | DIRECTOR ELECTIONS                            |           9814 |                0 | FOR         |                                     9814 | FOR                         |  |
| XENCOR, INC.                     | 98401F105 | 06/12/2025     | Election of Director to serve until the next Annual Meeting and until their successors are duly elected and qualified: Mr. Todd E. Simpson                                                                                                                                                                                                                                                                                                                                                                                                                                               | DIRECTOR ELECTIONS                            |           9814 |                0 | FOR         |                                     9814 | FOR                         |  |
| XENCOR, INC.                     | 98401F105 | 06/12/2025     | To ratify the selection by the Audit Committee of the Board of Directors of KPMG LLP as the independent registered public accounting firm of the Company for its fiscal year ending December 31, 2025.                                                                                                                                                                                                                                                                                                                                                                                   | AUDIT-RELATED                                 |           9814 |                0 | FOR         |                                     9814 | FOR                         |  |
| XENCOR, INC.                     | 98401F105 | 06/12/2025     | To approve the proposed amendment and restatement of the Company's 2023 Equity Incentive Plan to increase the number of authorized shares reserved for issuance thereunder by 3,000,000 shares.                                                                                                                                                                                                                                                                                                                                                                                          | COMPENSATION                                  |           9814 |                0 | AGAINST     |                                     9814 | AGAINST                     |  |
| XENCOR, INC.                     | 98401F105 | 06/12/2025     | To approve, on an advisory (non-binding) basis, the compensation of the Company's named executive officers, as disclosed in the accompanying Proxy Statement.                                                                                                                                                                                                                                                                                                                                                                                                                            | SECTION 14A SAY-ON-PAY VOTES                  |           9814 |                0 | FOR         |                                     9814 | FOR                         |  |
| ZENTALIS PHARMACEUTICALS, INC.   | 98943L107 | 06/17/2025     | DIRECTOR: Scott Myers                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    | DIRECTOR ELECTIONS                            |          67401 |                0 | FOR         |                                    67401 | FOR                         |  |
| ZENTALIS PHARMACEUTICALS, INC.   | 98943L107 | 06/17/2025     | DIRECTOR: Karan Takhar                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   | DIRECTOR ELECTIONS                            |          67401 |                0 | ABSTAIN     |                                    67401 | AGAINST                     |  |
| ZENTALIS PHARMACEUTICALS, INC.   | 98943L107 | 06/17/2025     | DIRECTOR: Luke Walker, M.D                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               | DIRECTOR ELECTIONS                            |          67401 |                0 | ABSTAIN     |                                    67401 | AGAINST                     |  |
| ZENTALIS PHARMACEUTICALS, INC.   | 98943L107 | 06/17/2025     | To ratify the appointment of Ernst  Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2025.                                                                                                                                                                                                                                                                                                                                                                                                                                         | AUDIT-RELATED                                 |          67401 |                0 | FOR         |                                    67401 | FOR                         |  |
| ZENTALIS PHARMACEUTICALS, INC.   | 98943L107 | 06/17/2025     | To approve, on an advisory (non-binding) basis, the compensation of our named executive officers.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        | SECTION 14A SAY-ON-PAY VOTES                  |          67401 |                0 | AGAINST     |                                    67401 | AGAINST                     |  |
| ZYMEWORKS INC.                   | 98985Y108 | 12/10/2024     | DIRECTOR: Kenneth Galbraith                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              | DIRECTOR ELECTIONS                            |          13386 |                0 | ABSTAIN     |                                    13386 | AGAINST                     |  |
| ZYMEWORKS INC.                   | 98985Y108 | 12/10/2024     | DIRECTOR: Susan Mahony                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   | DIRECTOR ELECTIONS                            |          13386 |                0 | ABSTAIN     |                                    13386 | AGAINST                     |  |
| ZYMEWORKS INC.                   | 98985Y108 | 12/10/2024     | DIRECTOR: Kelvin Neu                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     | DIRECTOR ELECTIONS                            |          13386 |                0 | ABSTAIN     |                                    13386 | AGAINST                     |  |
| ZYMEWORKS INC.                   | 98985Y108 | 12/10/2024     | DIRECTOR: Scott Platshon                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 | DIRECTOR ELECTIONS                            |          13386 |                0 | FOR         |                                    13386 | FOR                         |  |
| ZYMEWORKS INC.                   | 98985Y108 | 12/10/2024     | Advisory vote on the compensation of our named executive officers.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       | SECTION 14A SAY-ON-PAY VOTES                  |          13386 |                0 | FOR         |                                    13386 | FOR                         |  |
| ZYMEWORKS INC.                   | 98985Y108 | 12/10/2024     | Ratification of the appointment of KPMG LLP, chartered professional accountants, as auditors for the year ending December 31, 2024.                                                                                                                                                                                                                                                                                                                                                                                                                                                      | AUDIT-RELATED                                 |          13386 |                0 | FOR         |                                    13386 | FOR                         |  |

## N-PX: Signature Block

**Reporting Person:** ETF Series Solutions

**By (Signature):** Kristina Nelson

**By (Printed Signature):** Kristina Nelson

**By (Title):** President

**Date:** 08/26/2025